<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pmedf="http://predictmedix.com/20220131"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pmedf-20220131.xsd" xlink:type="simple"/>
    <context id="C_20210201to20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="C_20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:DirectorsOfficersAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantTenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:DirectorsOfficersAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeOnCompletionOfAdditionalMilestonesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheThreeOnCompletionOfAdditionalMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeOnExpiryTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheThreeOnExpiryTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFiveMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFiveMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="pmedf:VestingScheduleAxis">pmedf:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:StockOptionsGrantAxis">pmedf:StockOptionsGrantFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">pmedf:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyOneSevenTwoZeroTwoFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireJulyOneSevenTwoZeroTwoFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyOneSevenTwoZeroTwoFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireJulyOneSevenTwoZeroTwoFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchOneZeroTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireMarchOneZeroTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchOneZeroTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireMarchOneZeroTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchThreeZeroTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireMarchThreeZeroTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchThreeZeroTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireMarchThreeZeroTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchTwoThreeTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireMarchTwoThreeTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchTwoThreeTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireMarchTwoThreeTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireDecemberNineTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireDecemberNineTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireDecemberNineTwoZeroTwoTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireDecemberNineTwoZeroTwoTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyThreeZeroTwoZeroTwoThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireJulyThreeZeroTwoZeroTwoThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyThreeZeroTwoZeroTwoThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionsOutstandingByExpirationDateAxis">pmedf:ExpireJulyThreeZeroTwoZeroTwoThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20190923_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-23</instant>
        </period>
    </context>
    <context id="C_20180201to20180215_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-15</endDate>
        </period>
    </context>
    <context id="C_20180701to20180716_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-07-16</endDate>
        </period>
    </context>
    <context id="C_20180716_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-16</instant>
        </period>
    </context>
    <context id="C_20220131_srtStatementGeographicalAxis_countryIN">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullTypesOfRisksAxis_ifrsfullCreditRiskMember_srtMajorCustomersAxis_pmedfOneCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pmedf:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-27</startDate>
            <endDate>2020-03-27</endDate>
        </period>
    </context>
    <context id="C_20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-27</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_deiEntityListingsExchangeAxis_pmedfCanadianSecuritiesExchangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">pmedf:CanadianSecuritiesExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtDirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefFinancialOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefFinancialOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionExerciseAxis">pmedf:OptionExerciseOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:OptionExerciseAxis">pmedf:OptionExerciseTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">pmedf:SubsidiariesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20190201to20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-21</endDate>
        </period>
    </context>
    <context id="C_20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-21</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:InfectiousDiseaseSymptomScreeningSolutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:MobilewellbeingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfStudyOnDetectionTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:StudyOnDetectionTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfStudyOnDetectionTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">pmedf:StudyOnDetectionTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:ComponentsOfDeferredTaxAssetsAxis">pmedf:NonCapitalLossesAvailableForFuturePeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:ComponentsOfDeferredTaxAssetsAxis">pmedf:NonCapitalLossesAvailableForFuturePeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfShareIssuanceCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:ComponentsOfDeferredTaxAssetsAxis">pmedf:ShareIssuanceCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfShareIssuanceCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:ComponentsOfDeferredTaxAssetsAxis">pmedf:ShareIssuanceCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:ComponentsOfDeferredTaxAssetsAxis">pmedf:PropertyEquipmentAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pmedf:ComponentsOfDeferredTaxAssetsAxis">pmedf:PropertyEquipmentAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:NonCapitalLossesAvailableForFuturePeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:NonCapitalLossesAvailableForFuturePeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:NonCapitalLossesAvailableForFuturePeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:NonCapitalLossesAvailableForFuturePeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:ShareIssuanceCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:ShareIssuanceCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:ShareIssuanceCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:ShareIssuanceCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:PropertyEquipmentAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:PropertyEquipmentAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:PropertyEquipmentAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">pmedf:PropertyEquipmentAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001868079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <unit id="CAD">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="CAD_per_share">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Percent">
        <measure>pure</measure>
    </unit>
    <unit id="Share">
        <measure>pmedf:Share</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="Year">
        <measure>pmedf:Year</measure>
    </unit>
    <dei:SecurityExchangeName
      contextRef="C_20210201to20220131_deiEntityListingsExchangeAxis_pmedfCanadianSecuritiesExchangeMember"
      id="Fxbrl_20220615134929130">NONE</dei:SecurityExchangeName>
    <dei:EntityCentralIndexKey
      contextRef="C_20210201to20220131"
      id="Fdei_EntityCentralIndexKey20220603151147813">0001868079</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20210201to20220131"
      id="Fdei_CurrentFiscalYearEndDate20220603151159140">--01-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20210201to20220131"
      id="Fdei_DocumentFiscalPeriodFocus20220603151234679">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20210201to20220131"
      id="Fdei_DocumentFiscalYearFocus20220603151247159">2022</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag
      contextRef="C_20210201to20220131"
      id="Fdei_AmendmentFlag20220603151302141">false</dei:AmendmentFlag>
    <dei:EntityFileNumber
      contextRef="C_20210201to20220131"
      id="Fdei_EntityFileNumber20220615120904669">000-00000</dei:EntityFileNumber>
    <dei:DocumentType
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615005948359">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615010433525">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615010529408">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615011155126">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615012213798">false</dei:DocumentShellCompanyReport>
    <dei:EntityRegistrantName
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615012149518">PREDICTMEDIX INC.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615012021457">77 King Street W.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615013254899">Suite 3000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615012859078">Toronto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615110554908">M5K 1G8</dei:EntityAddressPostalZipCode>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20210201to20220131"
      id="Fxbrl_202206150130442890">Z4</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressCountry
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615013044289">CA</dei:EntityAddressCountry>
    <dei:Security12bTitle
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615112906836">Common</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615112915746">PMED</dei:TradingSymbol>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220615020130177"
      unitRef="Shares">109051292</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentPeriodEndDate
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615121602968">2022-01-31</dei:DocumentPeriodEndDate>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615095538784">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615022325785">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615021041932">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615020837430">No</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615015745707">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615020614717">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615112410925">false</dei:EntityExTransitionPeriod>
    <dei:DocumentAccountingStandard
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615020447228">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615095433131">false</dei:EntityShellCompany>
    <dei:AuditorName
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603153341942">Harbourside CPA</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603153408803">Vancouver, Canada</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220615113913780">6498</dei:AuditorFirmId>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_22"
      unitRef="CAD">211302</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_25"
      unitRef="CAD">480051</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_32"
      unitRef="CAD">169545</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_35"
      unitRef="CAD">0</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_42"
      unitRef="CAD">211482</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_45"
      unitRef="CAD">111952</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_52"
      unitRef="CAD">49295</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_55"
      unitRef="CAD">155442</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentAssets
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_62"
      unitRef="CAD">641624</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_65"
      unitRef="CAD">747445</ifrs-full:CurrentAssets>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_82"
      unitRef="CAD">76255</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_85"
      unitRef="CAD">8188</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_92"
      unitRef="CAD">518778</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_95"
      unitRef="CAD">248010</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:Assets
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_102"
      unitRef="CAD">1236657</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_105"
      unitRef="CAD">1003643</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_172"
      unitRef="CAD">334452</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_175"
      unitRef="CAD">135354</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_182"
      unitRef="CAD">15220</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_185"
      unitRef="CAD">0</ifrs-full:CurrentDeferredIncomeOtherThanCurrentContractLiabilities>
    <ifrs-full:Liabilities
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_192"
      unitRef="CAD">349672</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_195"
      unitRef="CAD">135354</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_222"
      unitRef="CAD">5716131</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_225"
      unitRef="CAD">4031650</ifrs-full:IssuedCapital>
    <ifrs-full:WarrantReserve
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_232"
      unitRef="CAD">510483</ifrs-full:WarrantReserve>
    <ifrs-full:WarrantReserve
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_235"
      unitRef="CAD">115802</ifrs-full:WarrantReserve>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_242"
      unitRef="CAD">675560</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_245"
      unitRef="CAD">853848</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:RetainedEarnings
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_252"
      unitRef="CAD">-6015189</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_255"
      unitRef="CAD">-4133011</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_262"
      unitRef="CAD">886985</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_265"
      unitRef="CAD">868289</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603113807220_272"
      unitRef="CAD">1236657</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603113807220_275"
      unitRef="CAD">1003643</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_32"
      unitRef="CAD">134820</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_35"
      unitRef="CAD">0</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_42"
      unitRef="CAD">50000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_45"
      unitRef="CAD">0</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_52"
      unitRef="CAD">84820</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_55"
      unitRef="CAD">0</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_92"
      unitRef="CAD">33349</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_95"
      unitRef="CAD">13658</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_102"
      unitRef="CAD">79288</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_105"
      unitRef="CAD">3509</ifrs-full:AmortisationExpense>
    <ifrs-full:AuditorsRemunerationForAuditServices
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_112"
      unitRef="CAD">33983</ifrs-full:AuditorsRemunerationForAuditServices>
    <ifrs-full:AuditorsRemunerationForAuditServices
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_115"
      unitRef="CAD">38560</ifrs-full:AuditorsRemunerationForAuditServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_122"
      unitRef="CAD">175746</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_125"
      unitRef="CAD">178004</ifrs-full:ProfessionalFeesExpense>
    <pmedf:InvestorRelations
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_132"
      unitRef="CAD">99307</pmedf:InvestorRelations>
    <pmedf:InvestorRelations
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_135"
      unitRef="CAD">0</pmedf:InvestorRelations>
    <pmedf:LegalFees
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_142"
      unitRef="CAD">192615</pmedf:LegalFees>
    <pmedf:LegalFees
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_145"
      unitRef="CAD">138879</pmedf:LegalFees>
    <ifrs-full:AdministrativeExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_152"
      unitRef="CAD">269845</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_155"
      unitRef="CAD">217050</ifrs-full:AdministrativeExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_162"
      unitRef="CAD">508609</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_165"
      unitRef="CAD">221670</ifrs-full:SalesAndMarketingExpense>
    <pmedf:PatentAndTrademarkExpenses
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_172"
      unitRef="CAD">0</pmedf:PatentAndTrademarkExpenses>
    <pmedf:PatentAndTrademarkExpenses
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_175"
      unitRef="CAD">13622</pmedf:PatentAndTrademarkExpenses>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_182"
      unitRef="CAD">165342</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_185"
      unitRef="CAD">0</ifrs-full:WagesAndSalaries>
    <ifrs-full:RentalExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_192"
      unitRef="CAD">32147</ifrs-full:RentalExpense>
    <ifrs-full:RentalExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_195"
      unitRef="CAD">21500</ifrs-full:RentalExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_202"
      unitRef="CAD">72885</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_205"
      unitRef="CAD">26300</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_212"
      unitRef="CAD">182996</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_215"
      unitRef="CAD">946361</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:TransferAgentAndFilingFees
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_222"
      unitRef="CAD">51244</pmedf:TransferAgentAndFilingFees>
    <pmedf:TransferAgentAndFilingFees
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_225"
      unitRef="CAD">57908</pmedf:TransferAgentAndFilingFees>
    <ifrs-full:TravelExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_232"
      unitRef="CAD">33642</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_235"
      unitRef="CAD">31308</ifrs-full:TravelExpense>
    <ifrs-full:TransportationExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_242"
      unitRef="CAD">36000</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_245"
      unitRef="CAD">22500</ifrs-full:TransportationExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_252"
      unitRef="CAD">1966998</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_255"
      unitRef="CAD">1930829</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_262"
      unitRef="CAD">0</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_265"
      unitRef="CAD">346296</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLoss
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_272"
      unitRef="CAD">-1882178</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_275"
      unitRef="CAD">-1584533</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_302"
      unitRef="CAD">-1882178</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_305"
      unitRef="CAD">-1581691</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_312"
      unitRef="CAD">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_315"
      unitRef="CAD">-2842</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20210201to20220131"
      decimals="3"
      id="Fxbrl_20220603123451726_322"
      unitRef="CAD_per_share">-0.017</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20200201to20210131"
      decimals="3"
      id="Fxbrl_20220603123451726_325"
      unitRef="CAD_per_share">-0.016</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603123451726_332"
      unitRef="Shares">107925066</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123451726_335"
      unitRef="Shares">101195130</ifrs-full:WeightedAverageShares>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20200131"
      decimals="INF"
      id="Fxbrl_20220603135848852_22"
      unitRef="Shares">104054149</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_25"
      unitRef="CAD">4119484</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember"
      decimals="0"
      id="Fxbrl_20220603135848852_28"
      unitRef="CAD">123283</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_211"
      unitRef="CAD">15922</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_214"
      unitRef="CAD">-63093</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20200131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_217"
      unitRef="CAD">-2611940</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20200131"
      decimals="0"
      id="Fxbrl_20220603135848852_220"
      unitRef="CAD">1583656</ifrs-full:Equity>
    <pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603135848852_32"
      unitRef="Shares">-4000000</pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares>
    <ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_35"
      unitRef="CAD">-540000</ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_314"
      unitRef="CAD">65935</ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_317"
      unitRef="CAD">60620</ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_320"
      unitRef="CAD">-413445</ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_411"
      unitRef="CAD">946361</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_420"
      unitRef="CAD">946361</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <pmedf:IncreaseDecreaseThroughAcquisitionOfIntangibleAssetsShares
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603135848852_52"
      unitRef="Shares">50000</pmedf:IncreaseDecreaseThroughAcquisitionOfIntangibleAssetsShares>
    <pmedf:IncreaseDecreaseThroughAcquisitionOfIntangibleAssets
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_55"
      unitRef="CAD">53000</pmedf:IncreaseDecreaseThroughAcquisitionOfIntangibleAssets>
    <pmedf:IncreaseDecreaseThroughAcquisitionOfIntangibleAssets
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_520"
      unitRef="CAD">53000</pmedf:IncreaseDecreaseThroughAcquisitionOfIntangibleAssets>
    <pmedf:IncreaseDecreaseThroughExerciseOfOptionsShares
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603135848852_62"
      unitRef="Shares">1455000</pmedf:IncreaseDecreaseThroughExerciseOfOptionsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_65"
      unitRef="CAD">321685</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_611"
      unitRef="CAD">-108435</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_620"
      unitRef="CAD">213250</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <pmedf:IncreaseDecreaseThroughExerciseOfWarrantsShares
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603135848852_72"
      unitRef="Shares">100000</pmedf:IncreaseDecreaseThroughExerciseOfWarrantsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_75"
      unitRef="CAD">57481</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember"
      decimals="0"
      id="Fxbrl_20220603135848852_78"
      unitRef="CAD">-7481</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_720"
      unitRef="CAD">50000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603135848852_82"
      unitRef="Shares">58824</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_85"
      unitRef="CAD">20000</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_820"
      unitRef="CAD">20000</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices>
    <ifrs-full:ProfitLoss
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullNoncontrollingInterestsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_914"
      unitRef="CAD">-2842</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_917"
      unitRef="CAD">-1581691</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_920"
      unitRef="CAD">-1584533</ifrs-full:ProfitLoss>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20210131"
      decimals="INF"
      id="Fxbrl_20220603135848852_102"
      unitRef="Shares">101717973</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_105"
      unitRef="CAD">4031650</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember"
      decimals="0"
      id="Fxbrl_20220603135848852_108"
      unitRef="CAD">115802</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_1011"
      unitRef="CAD">853848</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20210131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_1017"
      unitRef="CAD">-4133011</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603135848852_1020"
      unitRef="CAD">868289</ifrs-full:Equity>
    <pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnitsShares
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603135848852_112"
      unitRef="Shares">3114569</pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnitsShares>
    <pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnits
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_115"
      unitRef="CAD">695404</pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnits>
    <pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnits
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember"
      decimals="0"
      id="Fxbrl_20220603135848852_118"
      unitRef="CAD">394681</pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnits>
    <pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnits
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603135848852_1120"
      unitRef="CAD">1090085</pmedf:IncreaseDecreaseThroughPrivatePlacementOfUnits>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_125"
      unitRef="CAD">3770</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603135848852_1220"
      unitRef="CAD">3770</ifrs-full:ShareIssueRelatedCost>
    <pmedf:IncreaseDecreaseThroughExerciseOfOptionsShares
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603135848852_132"
      unitRef="Shares">3968750</pmedf:IncreaseDecreaseThroughExerciseOfOptionsShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_135"
      unitRef="CAD">956597</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_1311"
      unitRef="CAD">-361284</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603135848852_1320"
      unitRef="CAD">595313</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_1411"
      unitRef="CAD">182996</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603135848852_1420"
      unitRef="CAD">182996</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603135848852_152"
      unitRef="Shares">250000</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_155"
      unitRef="CAD">36250</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603135848852_1520"
      unitRef="CAD">36250</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServices>
    <ifrs-full:ProfitLoss
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_1617"
      unitRef="CAD">-1882178</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603135848852_1620"
      unitRef="CAD">-1882178</ifrs-full:ProfitLoss>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220603135848852_172"
      unitRef="Shares">109051292</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="0"
      id="Fxbrl_20220603135848852_175"
      unitRef="CAD">5716131</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember"
      decimals="0"
      id="Fxbrl_20220603135848852_178"
      unitRef="CAD">510483</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_1711"
      unitRef="CAD">675560</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220131_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="0"
      id="Fxbrl_20220603135848852_1717"
      unitRef="CAD">-6015189</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603135848852_1720"
      unitRef="CAD">886985</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_32"
      unitRef="CAD">-1882178</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_35"
      unitRef="CAD">-1584533</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_52"
      unitRef="CAD">79288</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_55"
      unitRef="CAD">3509</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_62"
      unitRef="CAD">0</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_65"
      unitRef="CAD">346296</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_72"
      unitRef="CAD">182996</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_75"
      unitRef="CAD">946361</ifrs-full:AdjustmentsForSharebasedPayments>
    <pmedf:AdjustmentsForSharesIssuedForConsultingServices
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_82"
      unitRef="CAD">36250</pmedf:AdjustmentsForSharesIssuedForConsultingServices>
    <pmedf:AdjustmentsForSharesIssuedForConsultingServices
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_85"
      unitRef="CAD">8333</pmedf:AdjustmentsForSharesIssuedForConsultingServices>
    <pmedf:AdjustmentsForDecreaseIncreaseInSalesTaxReceivable
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_102"
      unitRef="CAD">-99530</pmedf:AdjustmentsForDecreaseIncreaseInSalesTaxReceivable>
    <pmedf:AdjustmentsForDecreaseIncreaseInSalesTaxReceivable
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_105"
      unitRef="CAD">-101819</pmedf:AdjustmentsForDecreaseIncreaseInSalesTaxReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_112"
      unitRef="CAD">106147</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_115"
      unitRef="CAD">-44965</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_122"
      unitRef="CAD">-169545</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_125"
      unitRef="CAD">0</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_132"
      unitRef="CAD">199098</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_135"
      unitRef="CAD">68837</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_142"
      unitRef="CAD">15220</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_145"
      unitRef="CAD">0</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities>
    <pmedf:AdjustmentForDecreaseIncreaseInNetAssetsFromDiscontinuedOperations
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_152"
      unitRef="CAD">0</pmedf:AdjustmentForDecreaseIncreaseInNetAssetsFromDiscontinuedOperations>
    <pmedf:AdjustmentForDecreaseIncreaseInNetAssetsFromDiscontinuedOperations
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_155"
      unitRef="CAD">-29064</pmedf:AdjustmentForDecreaseIncreaseInNetAssetsFromDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_162"
      unitRef="CAD">-1532254</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_165"
      unitRef="CAD">-1079637</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_192"
      unitRef="CAD">84754</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_195"
      unitRef="CAD">0</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_202"
      unitRef="CAD">333369</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_205"
      unitRef="CAD">195010</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_212"
      unitRef="CAD">-418123</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_215"
      unitRef="CAD">-195010</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_242"
      unitRef="CAD">1090085</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_245"
      unitRef="CAD">0</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_252"
      unitRef="CAD">3770</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_255"
      unitRef="CAD">0</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_262"
      unitRef="CAD">0</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_265"
      unitRef="CAD">2129</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_272"
      unitRef="CAD">0</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_275"
      unitRef="CAD">50000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_282"
      unitRef="CAD">595313</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_285"
      unitRef="CAD">213250</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_292"
      unitRef="CAD">1681628</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_295"
      unitRef="CAD">261121</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_312"
      unitRef="CAD">-268749</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_315"
      unitRef="CAD">-1013526</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:Cash
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_322"
      unitRef="CAD">480051</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20200131"
      decimals="0"
      id="Fxbrl_20220603160605269_325"
      unitRef="CAD">1493577</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_332"
      unitRef="CAD">211302</ifrs-full:Cash>
    <ifrs-full:Cash
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_335"
      unitRef="CAD">480051</ifrs-full:Cash>
    <ifrs-full:IncomeTaxesPaidRefund
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_352"
      unitRef="CAD">0</ifrs-full:IncomeTaxesPaidRefund>
    <ifrs-full:IncomeTaxesPaidRefund
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_355"
      unitRef="CAD">0</ifrs-full:IncomeTaxesPaidRefund>
    <pmedf:SharesIssuedForAcquisitionOfIntangibleAssets
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_412"
      unitRef="CAD">0</pmedf:SharesIssuedForAcquisitionOfIntangibleAssets>
    <pmedf:SharesIssuedForAcquisitionOfIntangibleAssets
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_415"
      unitRef="CAD">53000</pmedf:SharesIssuedForAcquisitionOfIntangibleAssets>
    <pmedf:SharesIssuedForPrepaymentAndExpenseForConsultingFees
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603160605269_432"
      unitRef="CAD">36250</pmedf:SharesIssuedForPrepaymentAndExpenseForConsultingFees>
    <pmedf:SharesIssuedForPrepaymentAndExpenseForConsultingFees
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603160605269_435"
      unitRef="CAD">20000</pmedf:SharesIssuedForPrepaymentAndExpenseForConsultingFees>
    <pmedf:DisclosureOfOrganizationAndNatureOfOperationsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603112740042">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;1.&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Organization and Nature of Operations&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Admiral Bay Resources Inc. ("Admiral") was incorporated in British Columbia on September 3, 1987. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective September 23, 2019, Admiral was part of a three-cornered amalgamation among Admiral, 2693980 Ontario Inc. (a wholly owned subsidiary of Admiral) and Cultivar Holdings Ltd. (the "Transaction"). Admiral completed the acquisition of all the issued and outstanding shares of Cultivar Holdings Ltd. by way of a three-cornered amalgamation, pursuant to which 2693980 Ontario Inc., amalgamated with Cultivar Holdings Ltd. Pursuant to the Transaction, each registered shareholder of Cultivar Holdings Ltd. received one (1) common share in the capital of the Admiral for each common share held, resulting in the issuance of an aggregate of 97,439,900 common shares to Cultivar Holdings Ltd. Shareholders. As part of the Transaction, warrants of Cultivar Holdings Ltd. were replaced with common share purchase warrants of Admiral.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At completion of the Transaction, Admiral changed its name to Cultivar Holdings Inc. (the "Company").&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 9, 2020, the Company announced that it has completed its name change from "Cultivar Holdings Inc." to "Predictmedix Inc." (the "Name Change"). The CUSIP number assigned to the Company's common shares following the name change is CUSIP 74040L100 (ISIN CA74040L1004). In connection with the Name Change, the Company's trading symbol, as listed on the CSE and the OTCQB have also been changed from "CULT" to "PMED", and from "CVRHF" to "PMEDF", respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 15, 2018, the Company had acquired a 49% interest in a newly incorporated Cultivar JA Limited, ("CJA") a corporation incorporated under the laws of Jamaica. The remaining 51% interest was owned by local Jamaican business partners. On March 27, 2020, the Company sold and discontinued its interests in CJA (Note 5).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 16, 2018, the Company had acquired a 100% interest in a newly incorporated CannIP Holdings Inc. (formerly 2639745 Ontario Inc.) ("Cann") a corporation incorporated under the laws of the province of Ontario. Cann is engaged in the development of cosmetic and edible product lines, as well as investment in technology to detect an individual influence of cannabis. The Company did a one for one share exchange with Cann and issued 29,800,000 common shares to the shareholders of Cann.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company, through its subsidiaries, is in the business of investment in technology to detect if an individual is under the influence of cannabis and to predict substance addiction. The Company is currently focusing on artificial intelligence ("AI") technologies which are targeting two specific areas: 1) workplace health and safety and 2) healthcare.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's corporate head office is located at 77 King Street W, Suite 3000, Toronto, Ontario, Canada, M5K 1G8.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </pmedf:DisclosureOfOrganizationAndNatureOfOperationsExplanatory>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="C_20190923_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="INF"
      id="Fxbrl_20220603112934772"
      unitRef="Shares">97439900</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20180201to20180215_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="2"
      id="Fxbrl_20220603113804297"
      unitRef="Percent">0.49</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="C_20180201to20180215_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="2"
      id="Fxbrl_20220603113816837"
      unitRef="Percent">0.51</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20180701to20180716_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesOneMember"
      decimals="2"
      id="Fxbrl_20220603113849756"
      unitRef="Percent">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="C_20180716_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesOneMember"
      decimals="INF"
      id="Fxbrl_20220603114520446"
      unitRef="Shares">29800000</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <pmedf:DisclosureOfBasisOfPresentationAndGoingConcernExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603113611623">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;text-indent:-22pt;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;2.&#160; &#160; &#160;&#160;&lt;/strong&gt;&lt;strong&gt;Basis of Presentation and Going Concern&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basis of Preparation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These consolidated financial statements have been prepared on the historical cost basis except for financial instruments recorded at fair value. In addition, these consolidated financial statements have been prepared using the accrual basis of accounting, except for cash flow information. The functional currency of the Company and its subsidiaries is the Canadian dollar, which is also the Company's reporting currency.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Statement of Compliance &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements have been prepared in accordance with International Accounting Standards ("IAS") 1, "Presentation of Consolidated Financial Statements" using accounting policies consistent with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB") and interpretations issued by the International Financial Reporting Interpretations Committee ("IFRIC").&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Basis of Consolidation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These consolidated financial statements include the accounts of the Company and its subsidiaries; Cultivar Holdings Ltd. and Cann from the date of acquisition. The Company has a 100% interest in Cann and in Cultivar Holdings Ltd. The Company had a 49% interest in CJA which was sold on March 27, 2020 (see note 5). All inter-company transactions and balances have been eliminated on consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:21.3pt;text-indent:1.2pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Going Concern Assumption&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These consolidated financial statements have been prepared using IFRS on a going concern basis, which presumes the realization of assets and discharge of liabilities in the normal course of business, for the next fiscal year. At January 31, 2022, the Company had cash and cash equivalents of $211,302, working capital of $291,952 and an accumulated deficit of $6,015,189. The continuing operations of the Company are dependent on generation of revenues and profits and funding to be provided by equity investors. The Company intends to finance its future requirements through a combination of equity and/or debt issuance. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;This uncertainty may cast significant doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not include any adjustments to the carrying value or presentation of assets or liabilities that might be necessary should the Company be unable to continue as a going concern. These adjustments could be material.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Significant Accounting Judgments and Estimates&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of these consolidated financial statements in compliance with IFRS requires management to make certain critical accounting estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, shareholders' equity, and the disclosure of contingent assets and liabilities, as at the date of the financial statements, and expenses for the years reported.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Critical Judgements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of these consolidated financial statements requires management to make judgements regarding the going concern of the Company (discussed above), as well as the determination of functional currency. The functional currency is the currency of the primary economic environment in which an entity operates and has been determined for each entity within the Company. The functional currency for the Company and its subsidiaries has been determined to be the Canadian dollar.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Key Sources of Estimation Uncertainty&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates and such differences could be significant.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Significant estimates made by management affecting the consolidated financial statements include:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Share-based payments&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Estimating fair value for granted stock options requires determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate also requires determining the most appropriate inputs to the valuation model including the expected life of the option, volatility, dividend yield, and rate of forfeitures and making assumptions about them.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Deferred tax assets &amp;amp; liabilities&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The estimation of income taxes includes evaluating the recoverability of deferred tax assets and liabilities based on an assessment of the Company's ability to utilize the underlying future tax deductions against future taxable income prior to expiry of those deductions. Management assesses whether it is probable that some or all of the deferred income tax assets and liabilities will not be realized. The ultimate realization of deferred tax assets and liabilities is dependent upon the generation of future taxable income, which in turn is dependent upon the successful discovery, extraction, development and commercialization of mineral reserves. To the extent that management's assessment of the Company's ability to utilize future tax deductions changes, the Company would be required to recognize more or fewer deferred tax assets or liabilities, and deferred income tax provisions or recoveries could be affected.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify"&gt;
          &lt;div/&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Key Sources of Estimation Uncertainty (Cont'd)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Useful life of property and equipment&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment is depreciated over its estimated useful life. Estimated useful lives are determined based on current facts and past experience and takes into consideration the anticipated physical life of the asset, the potential for technological obsolescence, and regulations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Useful life of intangible assets&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22.3pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The intangible asset is depreciated over its estimated useful life. Estimated useful lives are determined based on current facts and past experience and takes into consideration the anticipated life of the asset, the potential for technological obsolescence, and regulations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;COVID-19 Estimation Uncertainty &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company's business or ability to raise funds.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Approval of the consolidated financial statements&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These consolidated financial statements were authorized for issuance by the Board of Directors on May 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </pmedf:DisclosureOfBasisOfPresentationAndGoingConcernExplanatory>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesOneMember"
      decimals="2"
      id="Fxbrl_202206031145279650"
      unitRef="Percent">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="2"
      id="Fxbrl_20220603114527965"
      unitRef="Percent">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="2"
      id="Fxbrl_20220603114604075"
      unitRef="Percent">0.49</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603114645380"
      unitRef="CAD">211302</ifrs-full:CashAndCashEquivalents>
    <pmedf:WorkingCapital
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603114704346"
      unitRef="CAD">291952</pmedf:WorkingCapital>
    <ifrs-full:RetainedEarnings
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603114721556"
      unitRef="CAD">-6015189</ifrs-full:RetainedEarnings>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603134304234">
    &lt;p style="margin-left:22pt;text-align:justify;text-indent:-22pt;margin-top:14px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;3.&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Significant Accounting Policies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cash&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash comprises of cash held at banks and amounts held in trust. The majority of the Company's cash is held in a major financial institution. The Company does not invest in any asset-backed deposits or investments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;


      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Income taxes&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax on profit or loss for the period comprises of current and deferred tax. Current tax is the expected tax paid or payable on the taxable income for the period, using tax rates enacted or substantively enacted at the statement of financial position date, and any adjustment to tax paid or payable in respect of previous periods.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax is recorded by providing for temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets are reduced to the extent that it is no longer probable that the related tax benefit will be realized. The effect on deferred tax assets and liabilities of a change in income tax rates is recognized in the period that includes the date of the enactment or substantive enactment of the change. Deferred tax assets and liabilities are presented separately except where there is a right of set-off within fiscal jurisdictions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;


      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Foreign currency translation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions are translated into Canadian dollars as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the transaction date, each asset, liability, revenue and expense denominated in a foreign currency is translated into Canadian dollars by the use of the exchange rate in effect at that date. At the period-end date, unsettled monetary assets and liabilities are translated into Canadian dollars by using the exchange rate in effect at the year-end date and the related translation differences are recognized in net loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-monetary assets and liabilities that are measured at historical cost are translated into Canadian dollars by using the exchange rate in effect at the date of the initial transaction and are not subsequently restated. Non-monetary assets and liabilities that are measured at fair value or a revalued amount are translated into Canadian dollars by using the exchange rate in effect at the date the value is determined, and the related translation differences are recognized in net loss or other comprehensive loss consistent with where the gain or loss on the underlying non-monetary asset or liability has been recognized.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;

    &lt;div/&gt;

      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Share Capital&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common shares and warrants are classified as shareholders' equity. Incremental costs directly attributable to the issue of common shares are recognized as a reduction of shareholders' equity, net of tax.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has adopted a relative fair value method with respect to the measurement of common shares and warrants issued as private placement units. The relative fair value method allocates value to each component on a pro-rata basis, based on the fair value of the components calculated independently of one another. The Company considers the market value of the common shares issued as fair value and measures the fair value of the warrant component of the unit using the Black-Scholes option pricing model. The unit value is then allocated, pro-rata, between the two components, with fair value attributed to the warrants being recorded to the Company's warrant reserve.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;


      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Loss per share&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss per share is computed by dividing the net loss applicable to common shares of the Company by the weighted average number of common shares outstanding for the relevant period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per common share is computed by dividing the net loss applicable to common shares by the sum of the weighted average number of common shares issued and outstanding and all additional common shares that would have been outstanding, if potentially dilutive instruments were converted.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;


      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Share-based payments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company grants stock options to buy common shares of the Company to consultants and service providers. The Company recognizes share-based compensation expense based on the estimated fair value of the options. A fair value measurement is made for each vesting instalment within each option grant and is determined using the Black-Scholes option-pricing model. The fair value of the options is recognized over the vesting period of the options granted as both share-based compensation expense and reserves. This includes a forfeiture estimate, which is revised for actual forfeitures in subsequent periods. The reserves account is subsequently reduced if the options are exercised, and the amount initially recorded is then credited to capital stock.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In situations where equity instruments are issued to non-employees and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of the goods or services received.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;

    &lt;div/&gt;
    &lt;div&gt;

        &lt;div&gt;
          &lt;p style="margin-left:22pt;background-color:rgb(255, 255, 255);text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Property and equipment&lt;/strong&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment is carried at cost, less accumulated amortization and accumulated impairment losses. The cost of the item of property and equipment consists of the purchase price, and any costs directly attributable to bringing the asset to the location and condition necessary for its intended use. An item of property and equipment is derecognized upon disposal or when no future economic benefits are expected to arise from the continued use of the asset. Any gain or loss arising on disposal of the asset, determined as the difference between the net disposal proceeds and the carrying amount of the asset, is recognized in the consolidated statement of loss and comprehensive loss. The cost of repairs and maintenance is expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company amortizes its property and equipment using the following rates:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                &lt;tr&gt;
                  &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% per annum, declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;

    &lt;/div&gt;

      &lt;div&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-left:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Intangible assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets are measured at cost less accumulated amortization and accumulated impairment losses. Amortization is recorded on a straight-line basis over the estimated useful life of the asset acquired, which varies depending on the nature of the intangible asset. Intangible assets are amortized from the date when they are available for use.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The estimated useful life is reviewed at the end of each reporting period with the effect of any changes in estimate being accounted for on a prospective basis. Internally incurred development costs are recognized as intangible assets when the following criteria are met:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;it is technically feasible to complete the intangible asset so that it will be available for use;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;management intends to complete the intangible asset and use or sell it;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;there is an ability to use or sell the intangible asset;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;it can be demonstrated how the intangible asset will generate probable future economic benefits;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;adequate technical, financial and other resources to complete the development and to use or sell the intangible asset are available; and&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f)&lt;span style="width:11.5pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;the expenditure attributable to the intangible asset during its development can be reliably measured.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets may relate to the Company's external development expenditures in relation to intellectual property development. Development expenditures that do not meet these criteria are recognized as an expense as incurred. Intangible assets with definite lives are assessed for impairment whenever there is an indication that the intangible asset may be impaired. These intangible assets will be amortized when they are ready for use. The amortization period and the amortization method are reviewed at the end of each reporting period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates on a prospective basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;

    &lt;div/&gt;

      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Impairment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying amount of the Company's assets is reviewed for an indication of impairment at the end of each reporting period. If an indication of impairment exists, the Company makes an estimate of the asset's recoverable amount. Individual assets are grouped for impairment assessment purposes at the lowest level at which there are identifiable cash flows that are largely independent of the cash flows of other groups of assets. Recoverable amount of an asset group is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are adjusted for the risks specific to the asset group and are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Where the carrying amount of an asset group exceeds its recoverable amount, the asset group is considered impaired and is written down to its recoverable amount. Impairment losses are recognized in profit or loss. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An assessment is made at each reporting date as to whether there is any indication that previously recognized impairment losses may no longer exist or may have decreased. If such indication exists, the recoverable amount is estimated. A previously recognized impairment loss is reversed only if there has been a change in the estimates used to determine the asset's recoverable amount. An impairment loss is reversed only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined, net of depreciation, if no impairment loss had been recognized.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;


      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Financial Instruments &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are recognized on the consolidated statements of financial position when the Company becomes a party to the contractual provisions of the financial instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following is the Company's accounting policy for financial instruments under IFRS 9:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Classification &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial instruments in the following categories: at fair value through profit and loss ("FVTPL"), at fair value through other comprehensive income (loss) ("FVTOCI") or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification of debt instruments is driven by the Company's business model for managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by-instrument basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or if the Company has opted to measure them at FVTPL.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div/&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Measurement &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial assets and liabilities at amortized cost &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and subsequently carried at amortized cost less any impairment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial assets and liabilities at FVTPL &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the consolidated statements of loss and comprehensive loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in the consolidated statements of loss and comprehensive loss in the period in which they arise.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Debt investments at FVOCI &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These assets are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Equity investments at FVOCI &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Impairment of financial assets at amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the Company measures the loss allowance for the financial asset at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the Company measures the loss allowance for the financial asset at an amount equal to the twelve month expected credit losses. The Company shall recognize in the consolidated statements of loss and comprehensive loss, as an impairment gain or loss, the amount of expected credit losses (or reversal) that is required to adjust the loss allowance at the reporting date to the amount that is required to be recognized.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Derecognition &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial assets &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div/&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial liabilities &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expired. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and / or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gains and losses on derecognition are generally recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's financial assets and liabilities are classified as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-left:36pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

              &lt;tr&gt;
                &lt;td style="width:50%;white-space:nowrap"&gt;
                  &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Asset or Liability&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="width:50%;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Classification&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FVTPL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines the fair value of financial instruments according to the following hierarchy based on the amount of observable inputs used to value the instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1 &#x2013; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions occur in sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2 &#x2013; Pricing inputs are other than quoted prices in active markets included in Level 1. Prices in Level 2 are either directly or indirectly observable as of the reporting date. Level 2 valuations are based on inputs, including quoted forward prices for commodities, time value and volatility factors, which can be substantially observed or corroborated in the marketplace.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3 &#x2013; Valuations in this level are those with inputs for the asset or liability that are not based on observable market data.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash has been measured at fair value using Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Impairment of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets are assessed at each reporting date to determine whether there is objective evidence that they are impaired. A financial asset is impaired if objective evidence indicates that a loss event has occurred after the initial recognition of the asset and that the loss event had a negative effect on the estimated future cash flows of that asset that can be estimated reliably.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div/&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:14pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An impairment loss in respect of a financial asset measured at amortized cost is calculated as the difference between its carrying amount and the present value of the estimated future cash flows discounted at the asset's original effective interest rate. Losses are recognized in profit or loss and reflected in a separate line item. When a subsequent event causes the amount of impairment loss to decrease, the decrease in impairment loss is reversed through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:27pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:32pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue is recognized at an amount that reflects the expected consideration receivable in exchange for transferring goods or services to a customer, applying the following five steps:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Identify the contract with a customer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Determine the transaction price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Allocate the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Recognize revenue when (or as) the entity satisfies a performance obligation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:32pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Under IFRS 15, the Company classified its revenue as being principally derived from the following source:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;ul style="padding-left:0pt;list-style-type:disc"&gt;
          &lt;li style="margin-left:41.5pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Screening services revenue on deployment of safe entry stations for use of the Company's technology.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
        &lt;/ul&gt;
        &lt;p style="margin-left:50pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from the sale of screening services is recognized based on the transaction price. Upfront fees as set-up fees are included in the transaction price and allocated to the performance obligation in the contract. Revenue is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;

    &lt;div/&gt;

      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;New standards not yet adopted &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Classification of Liabilities as Current or Non-Current (Amendments to IAS 1) &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The IASB has published Classification of Liabilities as Current or Non-Current (Amendments to IAS 1) which clarifies the guidance on whether a liability should be classified as either current or non-current. The amendment a) clarify that the classification of liabilities as current or non-current should only be based on rights that are in place "at the end of the reporting period" b) clarify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, and c) make clear that settlement includes transfers to the counterparty of cash, equity instruments, other assets or services that result in extinguishment of the liability. This amendment is effective for annual periods beginning on or after January 1, 2022. Earlier application is permitted. The extent of the impact of adoption of this amendment has not yet been determined.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;

  </ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603121752376">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Cash&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash comprises of cash held at banks and amounts held in trust. The majority of the Company's cash is held in a major financial institution. The Company does not invest in any asset-backed deposits or investments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603121818071">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Income taxes&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax on profit or loss for the period comprises of current and deferred tax. Current tax is the expected tax paid or payable on the taxable income for the period, using tax rates enacted or substantively enacted at the statement of financial position date, and any adjustment to tax paid or payable in respect of previous periods.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax is recorded by providing for temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets are reduced to the extent that it is no longer probable that the related tax benefit will be realized. The effect on deferred tax assets and liabilities of a change in income tax rates is recognized in the period that includes the date of the enactment or substantive enactment of the change. Deferred tax assets and liabilities are presented separately except where there is a right of set-off within fiscal jurisdictions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603133815697">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Foreign currency translation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions are translated into Canadian dollars as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the transaction date, each asset, liability, revenue and expense denominated in a foreign currency is translated into Canadian dollars by the use of the exchange rate in effect at that date. At the period-end date, unsettled monetary assets and liabilities are translated into Canadian dollars by using the exchange rate in effect at the year-end date and the related translation differences are recognized in net loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-monetary assets and liabilities that are measured at historical cost are translated into Canadian dollars by using the exchange rate in effect at the date of the initial transaction and are not subsequently restated. Non-monetary assets and liabilities that are measured at fair value or a revalued amount are translated into Canadian dollars by using the exchange rate in effect at the date the value is determined, and the related translation differences are recognized in net loss or other comprehensive loss consistent with where the gain or loss on the underlying non-monetary asset or liability has been recognized.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603133828345">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Share Capital&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Common shares and warrants are classified as shareholders' equity. Incremental costs directly attributable to the issue of common shares are recognized as a reduction of shareholders' equity, net of tax.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has adopted a relative fair value method with respect to the measurement of common shares and warrants issued as private placement units. The relative fair value method allocates value to each component on a pro-rata basis, based on the fair value of the components calculated independently of one another. The Company considers the market value of the common shares issued as fair value and measures the fair value of the warrant component of the unit using the Black-Scholes option pricing model. The unit value is then allocated, pro-rata, between the two components, with fair value attributed to the warrants being recorded to the Company's warrant reserve.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603133855971">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Loss per share&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss per share is computed by dividing the net loss applicable to common shares of the Company by the weighted average number of common shares outstanding for the relevant period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per common share is computed by dividing the net loss applicable to common shares by the sum of the weighted average number of common shares issued and outstanding and all additional common shares that would have been outstanding, if potentially dilutive instruments were converted.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603133916354">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Share-based payments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company grants stock options to buy common shares of the Company to consultants and service providers. The Company recognizes share-based compensation expense based on the estimated fair value of the options. A fair value measurement is made for each vesting instalment within each option grant and is determined using the Black-Scholes option-pricing model. The fair value of the options is recognized over the vesting period of the options granted as both share-based compensation expense and reserves. This includes a forfeiture estimate, which is revised for actual forfeitures in subsequent periods. The reserves account is subsequently reduced if the options are exercised, and the amount initially recorded is then credited to capital stock.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In situations where equity instruments are issued to non-employees and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of the goods or services received.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603134000319">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;background-color:rgb(255, 255, 255);text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Property and equipment&lt;/strong&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment is carried at cost, less accumulated amortization and accumulated impairment losses. The cost of the item of property and equipment consists of the purchase price, and any costs directly attributable to bringing the asset to the location and condition necessary for its intended use. An item of property and equipment is derecognized upon disposal or when no future economic benefits are expected to arise from the continued use of the asset. Any gain or loss arising on disposal of the asset, determined as the difference between the net disposal proceeds and the carrying amount of the asset, is recognized in the consolidated statement of loss and comprehensive loss. The cost of repairs and maintenance is expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company amortizes its property and equipment using the following rates:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                &lt;tr&gt;
                  &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;30% per annum, declining balance&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DepreciationRatePropertyPlantAndEquipment
      contextRef="C_20210201to20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOtherPropertyPlantAndEquipmentMember"
      decimals="2"
      id="Fxbrl_20220603140158963"
      unitRef="Percent">0.30</ifrs-full:DepreciationRatePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603134026168">
      &lt;div&gt;
        &lt;p style="text-align:justify;margin-top:10pt;margin-left:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Intangible assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets are measured at cost less accumulated amortization and accumulated impairment losses. Amortization is recorded on a straight-line basis over the estimated useful life of the asset acquired, which varies depending on the nature of the intangible asset. Intangible assets are amortized from the date when they are available for use.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The estimated useful life is reviewed at the end of each reporting period with the effect of any changes in estimate being accounted for on a prospective basis. Internally incurred development costs are recognized as intangible assets when the following criteria are met:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;it is technically feasible to complete the intangible asset so that it will be available for use;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;management intends to complete the intangible asset and use or sell it;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;there is an ability to use or sell the intangible asset;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;it can be demonstrated how the intangible asset will generate probable future economic benefits;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e)&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;adequate technical, financial and other resources to complete the development and to use or sell the intangible asset are available; and&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:54pt;text-indent:-18pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f)&lt;span style="width:11.5pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;the expenditure attributable to the intangible asset during its development can be reliably measured.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible assets may relate to the Company's external development expenditures in relation to intellectual property development. Development expenditures that do not meet these criteria are recognized as an expense as incurred. Intangible assets with definite lives are assessed for impairment whenever there is an indication that the intangible asset may be impaired. These intangible assets will be amortized when they are ready for use. The amortization period and the amortization method are reviewed at the end of each reporting period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates on a prospective basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603134041387">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Impairment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying amount of the Company's assets is reviewed for an indication of impairment at the end of each reporting period. If an indication of impairment exists, the Company makes an estimate of the asset's recoverable amount. Individual assets are grouped for impairment assessment purposes at the lowest level at which there are identifiable cash flows that are largely independent of the cash flows of other groups of assets. Recoverable amount of an asset group is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are adjusted for the risks specific to the asset group and are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Where the carrying amount of an asset group exceeds its recoverable amount, the asset group is considered impaired and is written down to its recoverable amount. Impairment losses are recognized in profit or loss. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An assessment is made at each reporting date as to whether there is any indication that previously recognized impairment losses may no longer exist or may have decreased. If such indication exists, the recoverable amount is estimated. A previously recognized impairment loss is reversed only if there has been a change in the estimates used to determine the asset's recoverable amount. An impairment loss is reversed only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined, net of depreciation, if no impairment loss had been recognized.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603134101890">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Financial Instruments &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and financial liabilities are recognized on the consolidated statements of financial position when the Company becomes a party to the contractual provisions of the financial instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following is the Company's accounting policy for financial instruments under IFRS 9:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Classification &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies its financial instruments in the following categories: at fair value through profit and loss ("FVTPL"), at fair value through other comprehensive income (loss) ("FVTOCI") or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification of debt instruments is driven by the Company's business model for managing the financial assets and their contractual cash flow characteristics. Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by-instrument basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or if the Company has opted to measure them at FVTPL.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div/&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Measurement &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial assets and liabilities at amortized cost &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and subsequently carried at amortized cost less any impairment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial assets and liabilities at FVTPL &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the consolidated statements of loss and comprehensive loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in the consolidated statements of loss and comprehensive loss in the period in which they arise.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Debt investments at FVOCI &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These assets are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in OCI. On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Equity investments at FVOCI &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Impairment of financial assets at amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the Company measures the loss allowance for the financial asset at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the Company measures the loss allowance for the financial asset at an amount equal to the twelve month expected credit losses. The Company shall recognize in the consolidated statements of loss and comprehensive loss, as an impairment gain or loss, the amount of expected credit losses (or reversal) that is required to adjust the loss allowance at the reporting date to the amount that is required to be recognized.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Derecognition &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial assets &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div/&gt;
        &lt;p style="margin-left:22.5pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Financial liabilities &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:22.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expired. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and / or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Gains and losses on derecognition are generally recognized in profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's financial assets and liabilities are classified as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-left:36pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

              &lt;tr&gt;
                &lt;td style="width:50%;white-space:nowrap"&gt;
                  &lt;p style="margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Asset or Liability&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                &lt;/td&gt;
                &lt;td style="width:50%;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Classification&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;FVTPL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:50%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:50%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortized cost&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company determines the fair value of financial instruments according to the following hierarchy based on the amount of observable inputs used to value the instrument.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1 &#x2013; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions occur in sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2 &#x2013; Pricing inputs are other than quoted prices in active markets included in Level 1. Prices in Level 2 are either directly or indirectly observable as of the reporting date. Level 2 valuations are based on inputs, including quoted forward prices for commodities, time value and volatility factors, which can be substantially observed or corroborated in the marketplace.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3 &#x2013; Valuations in this level are those with inputs for the asset or liability that are not based on observable market data.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash has been measured at fair value using Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Impairment of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial assets are assessed at each reporting date to determine whether there is objective evidence that they are impaired. A financial asset is impaired if objective evidence indicates that a loss event has occurred after the initial recognition of the asset and that the loss event had a negative effect on the estimated future cash flows of that asset that can be estimated reliably.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div/&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:14pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;An impairment loss in respect of a financial asset measured at amortized cost is calculated as the difference between its carrying amount and the present value of the estimated future cash flows discounted at the asset's original effective interest rate. Losses are recognized in profit or loss and reflected in a separate line item. When a subsequent event causes the amount of impairment loss to decrease, the decrease in impairment loss is reversed through profit or loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:27pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;Revenue recognition&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:32pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Revenue is recognized at an amount that reflects the expected consideration receivable in exchange for transferring goods or services to a customer, applying the following five steps:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Identify the contract with a customer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Determine the transaction price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Allocate the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-align:justify;text-indent:-12pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5.&lt;span style="display:inline-block;width:4.5pt"&gt;&#160;&lt;/span&gt;Recognize revenue when (or as) the entity satisfies a performance obligation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:32pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Under IFRS 15, the Company classified its revenue as being principally derived from the following source:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;ul style="padding-left:0pt;list-style-type:disc"&gt;
          &lt;li style="margin-left:41.5pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Screening services revenue on deployment of safe entry stations for use of the Company's technology.&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
        &lt;/ul&gt;
        &lt;p style="margin-left:50pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from the sale of screening services is recognized based on the transaction price. Upfront fees as set-up fees are included in the transaction price and allocated to the performance obligation in the contract. Revenue is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <pmedf:DescriptionOfAccountingPolicyForNewStandardsNotYetAdoptedExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603134113172">
      &lt;div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;New standards not yet adopted &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;Classification of Liabilities as Current or Non-Current (Amendments to IAS 1) &lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The IASB has published Classification of Liabilities as Current or Non-Current (Amendments to IAS 1) which clarifies the guidance on whether a liability should be classified as either current or non-current. The amendment a) clarify that the classification of liabilities as current or non-current should only be based on rights that are in place "at the end of the reporting period" b) clarify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, and c) make clear that settlement includes transfers to the counterparty of cash, equity instruments, other assets or services that result in extinguishment of the liability. This amendment is effective for annual periods beginning on or after January 1, 2022. Earlier application is permitted. The extent of the impact of adoption of this amendment has not yet been determined.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </pmedf:DescriptionOfAccountingPolicyForNewStandardsNotYetAdoptedExplanatory>
    <ifrs-full:DisclosureOfBusinessCombinationsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603125059307">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;4.&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Acquisitions&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended January 31, 2020, the Company completed the following acquisition:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective September 23, 2019, the Company was part of a three-cornered amalgamation among the Company, 2693980 Ontario Inc. (a wholly owned subsidiary) and Cultivar Holdings Ltd. (the "Transaction"). The result of the transaction was that Admiral acquired all the issued and outstanding securities of Cultivar Holdings Ltd. on the basis of one share of Admiral for each share of former Cultivar. All outstanding warrants to purchase former Cultivar shares were exchanged, on an equivalent basis, for warrants to purchase shares of the Company. At completion of the transaction, Admiral changed its name to Cultivar Holdings Inc. and former Cultivar was amalgamated into 2693980 Ontario Inc.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under IFRS, this was considered a Reverse Merger and Recapitalization (commonly referred to as a Reverse Take Over or "RTO"). The Company issued 6,514,249 shares valued at $0.21 per share, with a total value of $1,367,992 for the acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the acquired assets and liabilities assumed is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;div style="margin-bottom:0px"&gt;
                &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0);text-align:right;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0);text-align:right;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets acquired by the Company:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,448&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255);padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities assumed by the Company:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255);padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,127&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loans payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:1%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:right;width:15%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(107,525&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:2%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net liabilities assumed&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(122,079&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value of shares issued&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:1%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:right;width:15%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,367,992&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:2%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:2.25pt double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:2.25pt double rgb(0, 0, 0);text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,490,071&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:2.25pt double rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603132806221"
      unitRef="Share">6514249</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <pmedf:SharesIssuedPricePerShareAsOfAcquisitionDate
      contextRef="C_20190201to20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="2"
      id="Fxbrl_20220603132955255"
      unitRef="CAD_per_share">0.21</pmedf:SharesIssuedPricePerShareAsOfAcquisitionDate>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603133016646"
      unitRef="CAD">1367992</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603125123651">
              &lt;div style="margin-bottom:0px"&gt;
                &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0);text-align:right;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:2.25pt double rgb(0, 0, 0);text-align:right;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Assets acquired by the Company:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,448&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255);padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liabilities assumed by the Company:&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255);padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,127&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);padding-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loans payable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:1%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:right;width:15%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(107,525&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:2%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net liabilities assumed&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(122,079&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value of shares issued&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:1%;margin-bottom:0px"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:right;width:15%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,367,992&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid rgb(0, 0, 0);text-align:left;width:2%;margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0px;vertical-align:bottom;background-color:rgb(230, 239, 255)"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss on acquisition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:2.25pt double rgb(0, 0, 0);text-align:left;width:1%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:2.25pt double rgb(0, 0, 0);text-align:right;width:15%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,490,071&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid rgb(0, 0, 0);border-bottom:2.25pt double rgb(0, 0, 0);text-align:left;width:2%;background-color:rgb(230, 239, 255);margin-bottom:0px"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603125255223"
      unitRef="CAD">3448</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CurrentAssetsRecognisedAsOfAcquisitionDate
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603125305333"
      unitRef="CAD">1125</ifrs-full:CurrentAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603125324543"
      unitRef="CAD">19127</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603125345871"
      unitRef="CAD">107525</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603125402111"
      unitRef="CAD">-122079</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603125605770"
      unitRef="CAD">1367992</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <pmedf:GainLossOnAcquisition
      contextRef="C_20200131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_ifrsfullSubsidiariesMember"
      decimals="0"
      id="Fxbrl_20220603125630743"
      unitRef="CAD">-1490071</pmedf:GainLossOnAcquisition>
    <ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603150715674">
        &lt;div&gt;
          &lt;p style="text-align:justify;text-indent:-22pt;margin-left:22pt;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;5.&lt;span style="display:inline-block;width:14pt"&gt;&#160;&lt;/span&gt;Sale of interest in Cultivar JA Limited&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 27, 2020, the Company entered into a sale agreement (the "Sale Agreement") with respect to its 49% interest in Cultivar JA Limited ("Cultivar JA"), which holds a provisional cannabis cultivation license in Jamaica.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the terms of the Sale Agreement, the Company's wholly-owned subsidiary, Cultivar Holdings Ltd., agreed to sell its 49% interest in Cultivar JA and all related royalty interests to the principals of Cultivar JA in exchange for the principals of Cultivar JA agreeing to return and cancel 4,000,000 common shares of the Company owned by the principals. In addition, the principals also agreed to terminate their right to receive an additional 500,000 common shares of the Company which had been reserved for issuance upon Jamaica's Licensing Authority issuing final approval for Cultivar JA's license.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The sale agreement constituted a discontinued operation involving the loss of control of Cultivar JA by the Company. A discontinued operation is a component of the Company's business that represents a separate major line of business or a geographical area of operations that has been disposed of or is held for sale. Classification as a discontinued operation occurs upon disposal or earlier if the operation meets the criteria to be classified as held for sale. When an operation is classified as a discontinued operation the comparative statement of comprehensive loss and cash flow operation is re-presented as if the operation had been discontinued from the start of the comparative period.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The sale agreement constituted a discontinued operation of the Company effective March 27, 2020. As a result, all the assets and liabilities of Cultivar JA have been removed from the statement of financial position of the Company. The cancellation of 4,000,000 shares of the Company have been valued at $540,000, being the fair value of the shares on the date of the sale transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The expenses of Cultivar JA have been determined to be a discontinued operation by the Company, and as a result, have been disclosed separately on the statement of income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For the&lt;br/&gt;year&lt;br/&gt;ended&lt;br/&gt;January 31, 2022 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For the&lt;br/&gt;year&lt;br/&gt;ended&lt;br/&gt;January 31, 2021 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expenses: &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2,871&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;687&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Travel, entertainment and related&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2,014&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Net loss for the period prior to the sale transaction&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;(5,572&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gain on divestiture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;351,868&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:15pt;text-indent:-15pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;346,296&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;
                        &lt;p&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="2"
      id="Fxbrl_20220603151652976"
      unitRef="Percent">0.49</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="2"
      id="Fxbrl_20220603151711711"
      unitRef="Percent">0.49</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares
      contextRef="C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="INF"
      id="Fxbrl_20220603151819798"
      unitRef="Shares">-4000000</pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares>
    <pmedf:AdditionalSharesTerminated
      contextRef="C_20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="INF"
      id="Fxbrl_20220603153854504"
      unitRef="Shares">500000</pmedf:AdditionalSharesTerminated>
    <pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares
      contextRef="C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="INF"
      id="Fxbrl_20220603152136026"
      unitRef="Shares">-4000000</pmedf:IncreaseDecreaseThroughDisposalOfSubsidiaryShares>
    <ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary
      contextRef="C_20200327to20200327_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603152706041"
      unitRef="CAD">-540000</ifrs-full:IncreaseDecreaseThroughDisposalOfSubsidiary>
    <ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603150806314">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For the&lt;br/&gt;year&lt;br/&gt;ended&lt;br/&gt;January 31, 2022 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For the&lt;br/&gt;year&lt;br/&gt;ended&lt;br/&gt;January 31, 2021 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:center;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expenses: &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2,871&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;687&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Travel, entertainment and related&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;2,014&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Net loss for the period prior to the sale transaction&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;(5,572&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-left:15pt;text-indent:-15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Gain on divestiture&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;351,868&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:15pt;text-indent:-15pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Income (loss) from discontinued operations, net of tax&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;346,296&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;
                        &lt;p&gt;&#160;&lt;/p&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory>
    <ifrs-full:AmortisationExpense
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151439945"
      unitRef="CAD">0</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense
      contextRef="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151023576"
      unitRef="CAD">2871</ifrs-full:AmortisationExpense>
    <ifrs-full:InterestExpense
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151506282"
      unitRef="CAD">0</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151047382"
      unitRef="CAD">687</ifrs-full:InterestExpense>
    <ifrs-full:TravelExpense
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151518000"
      unitRef="CAD">0</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151146053"
      unitRef="CAD">2014</ifrs-full:TravelExpense>
    <pmedf:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151528025"
      unitRef="CAD">0</pmedf:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations>
    <pmedf:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations
      contextRef="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151214220"
      unitRef="CAD">-5572</pmedf:ProfitLossBeforeOtherIncomeAndGainLossOnSaleOfEquipmentFromDiscontinuedOperations>
    <ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151542987"
      unitRef="CAD">0</ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation>
    <ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation
      contextRef="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151236510"
      unitRef="CAD">351868</ifrs-full:GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20210201to20220131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151555528"
      unitRef="CAD">0</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="0"
      id="Fxbrl_20220603151301904"
      unitRef="CAD">346296</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <pmedf:DisclosureOfPrepaidExpensesExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603115436957">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;6.&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Prepaid Expenses&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Prepaid expenses as of January 31, 2022 include $nil (2021: $70,060) to conduct a study to further validate its proprietary impairment detection technology for both alcohol and cannabis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </pmedf:DisclosureOfPrepaidExpensesExplanatory>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfStudyOnDetectionTechnologyMember"
      decimals="0"
      id="Fxbrl_20220603115453822"
      unitRef="CAD">0</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="C_20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfStudyOnDetectionTechnologyMember"
      decimals="0"
      id="Fxbrl_20220603115459476"
      unitRef="CAD">70060</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603113520811">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;7.&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Property and Equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;vertical-align:middle"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;
                      &lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Leasehold&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;strong&gt;Improvement&lt;/strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;vertical-align:middle"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,953&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,916&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,869&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,585&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,916&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,501&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,368&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,368&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84,755&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84,755&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;98,123&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;98,123&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Accumulated Amortization&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,749&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,929&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,678&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,509&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,509&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,078&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,929&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,007&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,180&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,180&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,688&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,688&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,868&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,868&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Net Carrying Amounts&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;As at January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,255&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,255&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;As at January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,188&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,188&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603113504050">
              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;vertical-align:middle"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Equipment&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;
                      &lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Leasehold&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;strong&gt;Improvement&lt;/strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="background-color:rgb(255, 255, 255);border-top:1.5pt solid rgb(0, 0, 0);border-bottom:1.5pt solid rgb(0, 0, 0);text-align:center;white-space:nowrap;vertical-align:middle"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,953&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,916&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31,869&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8,585&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,916&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18,501&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,368&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,368&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84,755&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84,755&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;98,123&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;98,123&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Accumulated Amortization&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,749&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,929&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,678&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,509&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,509&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,078&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,929&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,007&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,180&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,180&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,688&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,688&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,868&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,868&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Net Carrying Amounts&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;As at January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,255&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76,255&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;As at January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,188&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,188&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_22"
      unitRef="CAD">21953</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_25"
      unitRef="CAD">9916</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603112015034_28"
      unitRef="CAD">31869</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_32"
      unitRef="CAD">8585</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_35"
      unitRef="CAD">9916</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603112015034_38"
      unitRef="CAD">18501</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_42"
      unitRef="CAD">13368</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_45"
      unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603112015034_48"
      unitRef="CAD">13368</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_52"
      unitRef="CAD">84755</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_55"
      unitRef="CAD">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603112015034_58"
      unitRef="CAD">84755</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_62"
      unitRef="CAD">98123</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_65"
      unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603112015034_68"
      unitRef="CAD">98123</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_82"
      unitRef="CAD">-5749</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_85"
      unitRef="CAD">-5929</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_88"
      unitRef="CAD">-11678</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_92"
      unitRef="CAD">3509</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_95"
      unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_98"
      unitRef="CAD">3509</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_102"
      unitRef="CAD">-4078</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_105"
      unitRef="CAD">-5929</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_108"
      unitRef="CAD">-10007</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_112"
      unitRef="CAD">-5180</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_115"
      unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_118"
      unitRef="CAD">-5180</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_122"
      unitRef="CAD">16688</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_125"
      unitRef="CAD">0</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_128"
      unitRef="CAD">16688</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_132"
      unitRef="CAD">-21868</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_135"
      unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAmortisationAndImpairmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_138"
      unitRef="CAD">-21868</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_152"
      unitRef="CAD">76255</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_155"
      unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603112015034_158"
      unitRef="CAD">76255</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullOfficeEquipmentMember"
      decimals="0"
      id="Fxbrl_20220603112015034_162"
      unitRef="CAD">8188</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131_ifrsfullClassesOfPropertyPlantAndEquipmentAxis_ifrsfullLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20220603112015034_165"
      unitRef="CAD">0</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603112015034_168"
      unitRef="CAD">8188</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603170135333">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;8.&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Intangible Assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;a) On July 21, 2020, the Company completed the acquisition of MobileWellbeing ("MWB"), an innovative, feature rich, Telemedicine Remote Patient Monitoring platform that will integrate with the Company's Artificial Intelligence ("AI") driven rapid screening system for infectious diseases, including COVID-19. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The consideration for the purchase was satisfied by payment in cash for $25,000, issuance of 20,000 shares and additional 30,000 shares to be issued on the 90&lt;sup&gt;th&lt;/sup&gt; day of close. &lt;/span&gt;Consideration paid in the form of equity instruments is being considered share- based payment within the scope of IFRS 2 Share-based Payment and this asset acquisition is fair valued for a total consideration for $78,000 at the point control was obtained.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The acquisition has contingent considerations and royalty payments on achievement of certain milestones. The Company shall pay royalty of 20 percent of gross sales from the first $2.5 million in sales generated exclusively from the MWB platform. In addition, the Company is obligated to issue an additional 200,000 common shares commencing with the release of the initial version of the MWB platforms to the market and achievement of sales related milestones. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent consideration in an asset acquisition was discussed at the March 2016 IFRS Interpretations Committee (IFRIC) meeting. An accounting policy choice exists, therefore an entity may recognize a liability for the expected variable payments at the time control of the underlying asset is obtained or they may only recognize such a liability as the related activity that gives rise to the variability occurs. The Company has opted to recognize the liability only when the related activity that gives rise to the variability occurs.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Consideration&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash consideration on closing&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued shares (50,000 shares issued at $1.06/share)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;78,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;width:15%;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Purchase Price allocation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible asset- MWB remote patient monitoring platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;width:1%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;78,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;strong&gt;&#160;&lt;/strong&gt;The Company's other intangible asset relates to the development of &lt;span style="color:#201f1e"&gt;infectious disease symptom screening solution ("IDSS")&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has commenced amortization on the intangible assets on a straight line basis over the useful life estimated to be for 5 years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="text-align:justify;margin-left:22pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's intangible assets are comprised of the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:92.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;MWB &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;IDSS&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance at January 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,970&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;156,040&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;170,010&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;91,970&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;156,040&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;248,010&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;46,591&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;286,778&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333,369&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance at January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;138,561&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;442,818&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;581,379&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated amortization:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance as at January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,601&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance as at January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,601&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;&lt;strong&gt;Net Book Value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;91,970&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;156,040&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;248,010&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;119,571&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;399,207&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;518,778&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603152131390"
      unitRef="CAD">25000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <pmedf:SharesIssuedToAcquireIntangibleAssets
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="INF"
      id="Fxbrl_20220603152138145"
      unitRef="Shares">20000</pmedf:SharesIssuedToAcquireIntangibleAssets>
    <pmedf:AdditionalSharesIssuedToAcquireIntangibleAssetsOnNinetiethDayOfClose
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="INF"
      id="Fxbrl_20220603152151607"
      unitRef="Shares">30000</pmedf:AdditionalSharesIssuedToAcquireIntangibleAssetsOnNinetiethDayOfClose>
    <pmedf:ConsiderationTransferredForAcquisitionOfIntangibleAssets
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603152204152"
      unitRef="CAD">78000</pmedf:ConsiderationTransferredForAcquisitionOfIntangibleAssets>
    <pmedf:PercentageOfRoyaltyOfGrossSales
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="2"
      id="Fxbrl_20220603152217838"
      unitRef="Percent">0.20</pmedf:PercentageOfRoyaltyOfGrossSales>
    <pmedf:SalesApplicableToRoyalty
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="-5"
      id="Fxbrl_20220603152816720"
      unitRef="CAD">2500000</pmedf:SalesApplicableToRoyalty>
    <pmedf:AdditionalSharesIssuedToAcquireIntangibleAssetsOnReleaseOfInitialPlatforms
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="INF"
      id="Fxbrl_20220603153021109"
      unitRef="Shares">200000</pmedf:AdditionalSharesIssuedToAcquireIntangibleAssetsOnReleaseOfInitialPlatforms>
    <pmedf:DisclosureOfDetailedInformationAboutPurchasePriceAllocationOfIntangibleAssetsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603165937341">
              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Consideration&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:1.5pt solid #000000;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash consideration on closing&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issued shares (50,000 shares issued at $1.06/share)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;53,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;78,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:1.5pt solid #000000;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;width:15%;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Purchase Price allocation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible asset- MWB remote patient monitoring platform&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;width:1%;text-align:left;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:0.75pt solid #000000;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;78,000&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutPurchasePriceAllocationOfIntangibleAssetsExplanatory>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603161116738"
      unitRef="CAD">25000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <pmedf:SharesIssuedToAcquireIntangibleAssetsIncludingClosing
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="INF"
      id="Fxbrl_20220603160034032"
      unitRef="Shares">50000</pmedf:SharesIssuedToAcquireIntangibleAssetsIncludingClosing>
    <pmedf:SharesIssuedToAcquireIntangibleAssetsValuePerShare
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="2"
      id="Fxbrl_20220603160040577"
      unitRef="CAD_per_share">1.06</pmedf:SharesIssuedToAcquireIntangibleAssetsValuePerShare>
    <pmedf:ValueOfSharesIssuedToAcquireIntangibleAssets
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603161224950"
      unitRef="CAD">53000</pmedf:ValueOfSharesIssuedToAcquireIntangibleAssets>
    <pmedf:ConsiderationTransferredForAcquisitionOfIntangibleAssets
      contextRef="C_20200701to20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603161242192"
      unitRef="CAD">78000</pmedf:ConsiderationTransferredForAcquisitionOfIntangibleAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603161303425"
      unitRef="CAD">78000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <pmedf:PurchasePriceAllocationOfIntangibleAssets
      contextRef="C_20200721_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603161327065"
      unitRef="CAD">78000</pmedf:PurchasePriceAllocationOfIntangibleAssets>
    <ifrs-full:AmortisationMethodIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      id="Fxbrl_20220603171947517">straight line</ifrs-full:AmortisationMethodIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      id="Fxbrl_20220603171954218">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603165951614">
              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:92.5pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;MWB &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;IDSS&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;&lt;strong&gt;Cost&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance at January 31, 2020&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;78,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,970&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;156,040&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;170,010&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Balance at January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;91,970&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;156,040&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;248,010&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;46,591&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;286,778&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333,369&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance at January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;138,561&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;442,818&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;581,379&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Accumulated amortization:&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance as at January 1, 2020&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance as at January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,601&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance as at January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,611&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,601&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;&lt;strong&gt;Net Book Value&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;91,970&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;156,040&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;248,010&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Balance, January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;119,571&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;399,207&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;518,778&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603163314912"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603163325741"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603163337611"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603163417630"
      unitRef="CAD">78000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603163455237"
      unitRef="CAD">0</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603163509004"
      unitRef="CAD">78000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603163628066_xbrl_20220603163417630"
      unitRef="CAD">13970</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603163628066_xbrl_20220603163455237"
      unitRef="CAD">156040</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603163628066_xbrl_20220603163509004"
      unitRef="CAD">170010</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603163658308_xbrl_20220603163314912"
      unitRef="CAD">91970</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603163658308_xbrl_20220603163325741"
      unitRef="CAD">156040</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603163658308_xbrl_20220603163337611"
      unitRef="CAD">248010</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603163807993"
      unitRef="CAD">46591</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603163814743"
      unitRef="CAD">286778</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603163821242"
      unitRef="CAD">333369</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164130241"
      unitRef="CAD">138561</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164145513"
      unitRef="CAD">442818</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullGrossCarryingAmountMember"
      decimals="0"
      id="Fxbrl_20220603164209154"
      unitRef="CAD">581379</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164221427"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164236833"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20200131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fxbrl_20220603164251402"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164308630"
      unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164337134"
      unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20200201to20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fxbrl_20220603164351187"
      unitRef="CAD">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164404209"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164412754"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fxbrl_20220603164420385"
      unitRef="CAD">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164438316"
      unitRef="CAD">-18990</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164450365"
      unitRef="CAD">-43611</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="C_20210201to20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fxbrl_20220603164500187"
      unitRef="CAD">-62601</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164513042"
      unitRef="CAD">-18990</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164523435"
      unitRef="CAD">-43611</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfullAccumulatedDepreciationAndAmortisationMember"
      decimals="0"
      id="Fxbrl_20220603164534411"
      unitRef="CAD">-62601</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164633940"
      unitRef="CAD">91970</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164654677"
      unitRef="CAD">156040</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603164726413"
      unitRef="CAD">248010</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="0"
      id="Fxbrl_20220603164742200"
      unitRef="CAD">119571</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfInfectiousDiseaseSymptomScreeningSolutionMember"
      decimals="0"
      id="Fxbrl_20220603164752669"
      unitRef="CAD">399207</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603164803654"
      unitRef="CAD">518778</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfLeasesExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603124739136">
        &lt;div&gt;
          &lt;p style="text-align:justify;text-indent:-22pt;margin-left:22pt;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;9.&lt;span style="display:inline-block;width:14pt"&gt;&#160;&lt;/span&gt;Leases&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Right-of-use assets of $nil (January 31, 2021- $nil) and total lease liability of $nil (January 31, 2021- $nil) have been removed from the statement of financial position of the Company as of January 31, 2021 on account of the sale of Company's interest in Cultivar JA (Note 5).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Right of use assets&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:9pt;text-indent:13.5pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company's right of use assets as at January 31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;padding-left:1.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,192&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,871&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,321&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:1.3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As at January 31, 2022 and 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Lease liability&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;At the commencement date of the leases, the lease liability was measured at the present value of the lease payments that were not paid at that date. The lease payments are discounted using an interest rate of 18% which is the Company's incremental borrowing rate.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liability interest expense recognized in profit and loss and lease payments recognized in the financing component of statement of cash flows are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;padding-left:1.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,189&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;687&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease payments made during the year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,129&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,747&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:1.3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As at January 31, 2022 and 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company's lease liability as at January 31, 2022 and 2021 was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;padding-left:1.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January&#160;&lt;/strong&gt;&lt;strong&gt;31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;padding-left:1.8pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liability - current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:3.1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liability - non- current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:1.3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total lease liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfLeasesExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603124510193"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603124530372"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603124524815"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603124540629"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603124712222">
              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;padding-left:1.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,192&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,871&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9,321&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:1.3pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As at January 31, 2022 and 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets
      contextRef="C_20200131"
      decimals="0"
      id="Fxbrl_20220603123953206_12"
      unitRef="CAD">12192</ifrs-full:RightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123953206_22"
      unitRef="CAD">2871</ifrs-full:DepreciationRightofuseAssets>
    <pmedf:DiscontinuanceOfBusinessRightOfUseAssets
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603123953206_32"
      unitRef="CAD">9321</pmedf:DiscontinuanceOfBusinessRightOfUseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603123953206_420"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603123953206_42"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603124720022">
              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;padding-left:1.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Balance as at January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,189&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Interest expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;687&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease payments made during the year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,129&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Discontinuance of business (Note 5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13,747&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:1.3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;As at January 31, 2022 and 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20200131"
      decimals="0"
      id="Fxbrl_20220603124119761_12"
      unitRef="CAD">15189</ifrs-full:LeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603124119761_22"
      unitRef="CAD">687</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603124119761_32"
      unitRef="CAD">2129</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <pmedf:DiscontinuanceOfBusinessLeases
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603124119761_42"
      unitRef="CAD">13747</pmedf:DiscontinuanceOfBusinessLeases>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603124119761_520"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603124119761_52"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <pmedf:DisclosureOfDetailedInformationAboutLeaseLiabilityExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603124728983">
              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;padding-left:1.55pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January&#160;&lt;/strong&gt;&lt;strong&gt;31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;border-top:1.5pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;padding-left:1.8pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:1.8pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liability - current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-left:3.1pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Lease liability - non- current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:1.3pt;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total lease liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutLeaseLiabilityExplanatory>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603124239761_22"
      unitRef="CAD">0</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603124239761_25"
      unitRef="CAD">0</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603124239761_35"
      unitRef="CAD">0</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603124239761_42"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603124239761_45"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603171749424">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;10.&lt;/strong&gt;&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Stock-based Compensation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company has established a stock option plan whereby officers, directors, employees and service providers may be granted options to purchase common shares at a fixed price. Vesting and expiry provisions are determined at the date of grant. The plan provides for the issuance of stock options to acquire up to 10% of the Company's issued and outstanding capital. The plan is a rolling plan as the number of shares reserved for issuance pursuant to the grant of stock options will increase as the Company's issued and outstanding share capital increases.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;Year ended January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;a) In October 2018, the Company granted options to a consultant to acquire a total of 250,000 common shares. These options were issued at an exercise price of $0.10 per share and vested 75,000 immediately, 37,500 at the date of engineering milestone (vested during the quarter ended July 31, 2019) and balance 137,500 on completion of additional milestones, including 75,000 on model development (vested during the quarter ended October 31, 2019) and 62,500 on project handover with an expiry term of two years. These options expired unexercised in October 2020. The fair value of each option used for the purpose of estimating the stock-based compensation was estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;border-collapse:collapse;width:100%;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2.26%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2021, the Company expensed $3,311, resulting in unvested stock-based compensation expense of $nil as of January 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;b) In November 2018, the Company granted options to a consultant to acquire a total of 100,000 common shares. These options were issued at an exercise price of $0.10 per share and vested 25,000 immediately, and 25,000 each on April 1, 2019, September 1, 2019 and March 1, 2020 with an expiry term of three years. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;border-collapse:collapse;width:100%;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.30%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2021, the Company expensed $260, resulting in unvested stock-based compensation expense of $nil as of January 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;c) On April 6, 2020, the Company granted options to its directors, officers and consultants to purchase up to 9,850,000 common shares. These options were issued at an exercise price of $0.15 per share and have varying vesting periods, with the majority being in equal installments over a quarterly basis throughout the term. These options have a term of one (1) year expiring on April 6, 2021. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.47%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;135%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2021, the Company expensed $742,833 relating to the vesting of options, resulting in unvested stock-based compensation expense of $nil as of January 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;d) On July 17, 2020, the Company granted options to a consultant to purchase up to 80,000 common shares. These options were issued at an exercise price of $1.02 per share and vest one year after date of grant. These options have a term of five (5) years expiring on July 17, 2025. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;border-collapse:collapse;width:100%;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.35%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;207%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;34,246&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2021, the Company expensed $40,603 relating to the vesting of options, resulting in unvested stock- based compensation expense of $34,246 as of January 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;e) On September 10, 2020, the Company granted options to a consultant to purchase up to 70,000 common shares. These options were issued at an exercise price of $0.54 per share and vest on completion of milestones, including 40,000 upon approval of a McGill University study and 30,000 upon completion of the study. The Company did not record any stock-based compensation on these options, as they have not yet vested as at January 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;f) On September 17, 2020, the Company granted options to a consultant to purchase up to 200,000 common shares. These options were issued at an exercise price of $0.54 per share and vest on date of grant. These options expire on March 30, 2022. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.26%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;189%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2021, the Company expensed $81,979, relating to the vesting of options, resulting in unvested stock- based compensation expense of $nil as of January 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;g) On September 21, 2020, the Company granted options to a consultant to purchase up to 250,000 common shares. These options were issued at an exercise price of $0.59 per share and vest in equal installments over a quarterly basis throughout the term. These options have a term of one (1) year expiring on September 21, 2021. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.23%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;188%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,958&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2021, the Company expensed $77,375 relating to the vesting of options, resulting in unvested stock- based compensation expense of $18,958 as of January 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As of January 31, 2021, there was $53,204 of unvested stock-based compensation expense.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;Year ended January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(a)&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;The Company expensed $34,246 relating to the vesting of options issued on July 17, 2020, resulting in unvested stock- based compensation expense of $nil as of January 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(b)&lt;span style="width:10.5pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;The Company expensed $18,958 relating to the vesting of options issued on September 21, 2020, resulting in unvested stock- based compensation expense of $nil as of January 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;(c)&lt;/strong&gt;&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;On March 23, 2021, the Company granted options to a consultant to purchase up to 250,000 common shares. These options were issued at an exercise price of $0.36 per share and vest equally over the next 3, 6, 9 and 12 months. These options have a term of one (1) year expiring on March 23, 2022. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.26%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;134.3%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,834&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:44pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2022, the Company expensed $50,675 relating to the vesting of options, resulting in unvested stock- based compensation expense of $1,834 as of January 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;(d)&lt;/strong&gt;&lt;span style="width:10pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;On June 9, 2021, the Company granted options to a consultant to purchase up to 250,000 common shares. These options were issued at an exercise price of $0.345 per share and vest equally over the next 3, 6, 9 and 12 months. These options have a term of 18 months expiring on December 9, 2022. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.32%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;146.38%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,778&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:44pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2022, the Company expensed $48,672 relating to the vesting of options, resulting in unvested stock- based compensation expense of $6,778 as of January 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="margin-left:44pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;Year ended January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;(e)&lt;/strong&gt;&lt;span style="width:11pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;On July 30, 2021, the Company granted options to a consultant to purchase up to 250,000 common shares. These options were issued at an exercise price of $0.25 per share and vest equally over the next 3, 6, 9 and 12 months. These options have a term of 18 months expiring on January 30, 2023. The fair value of each option used for the purpose of estimating the stock-based compensation is estimated using the Black-Scholes option pricing model with the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.38%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;131.33%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,826&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2022, the Company expensed $30,445 relating to the vesting of options, resulting in unvested stock- based compensation expense of $7,826 as of January 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As of January 31, 2022, there was a total of $16,438 of unvested stock-based compensation expense.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Continuity of the Company's options is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of&lt;br/&gt;Options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;350,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10,450,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(250,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,455,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.15&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,095,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;750,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(4,776,250&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(3,968,750&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.15&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;div style="margin-top:10pt"&gt;
            &lt;div/&gt;
            &lt;p style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As at January 31, 2022, the Company had the following share purchase options outstanding and exercisable:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

              &lt;div&gt;
                &lt;div style="margin-bottom:16px"&gt;
                  &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Remaining Life&lt;br/&gt;(Years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.46&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 10, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 30, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;187,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 23, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 9, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;July 30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;780,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <pmedf:OptionsAuthorizedUnderStockOptionPlanAsPercentageOfIssuedAndOutstandingCommonShares
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603191604489"
      unitRef="Percent">0.10</pmedf:OptionsAuthorizedUnderStockOptionPlanAsPercentageOfIssuedAndOutstandingCommonShares>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="INF"
      id="Fxbrl_20220603191623447"
      unitRef="Share">250000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="2"
      id="Fxbrl_20220603191701360"
      unitRef="CAD_per_share">0.1</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheOneMember"
      decimals="INF"
      id="Fxbrl_20220603191718409"
      unitRef="Share">75000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheTwoMember"
      decimals="INF"
      id="Fxbrl_20220603191751528"
      unitRef="Share">37500</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeMember"
      decimals="INF"
      id="Fxbrl_20220603191757234"
      unitRef="Share">137500</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeOnCompletionOfAdditionalMilestonesMember"
      decimals="INF"
      id="Fxbrl_20220603191834776"
      unitRef="Share">75000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeOnExpiryTermMember"
      decimals="INF"
      id="Fxbrl_20220603191842232"
      unitRef="Share">62500</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      id="Fxbrl_20220603191952010">two years</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      id="Fxbrl_20220603180957108">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;border-collapse:collapse;width:100%;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2.26%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="4"
      id="Fxbrl_20220603183424852"
      unitRef="Percent">0.0226</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="2"
      id="Fxbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="2"
      id="Fxbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="2"
      id="Fxbrl_20220603190159494"
      unitRef="Percent">1</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="0"
      id="Fxbrl_20220603190338759"
      unitRef="Year">2</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="0"
      id="Fxbrl_20220603190209109"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="0"
      id="Fxbrl_20220603192114459"
      unitRef="CAD">3311</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantOneMember"
      decimals="0"
      id="Fxbrl_20220606184527782"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="INF"
      id="Fxbrl_20220603192150607"
      unitRef="Share">100000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="2"
      id="Fxbrl_20220603192200014"
      unitRef="CAD_per_share">0.1</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheOneMember"
      decimals="INF"
      id="Fxbrl_20220603192212123"
      unitRef="Share">25000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheFourMember"
      decimals="INF"
      id="Fxbrl_202206031922232361"
      unitRef="Share">25000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheThreeMember"
      decimals="INF"
      id="Fxbrl_202206031922232360"
      unitRef="Share">25000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheTwoMember"
      decimals="INF"
      id="Fxbrl_20220603192223236"
      unitRef="Share">25000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      id="Fxbrl_20220603192238627">three years</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      id="Fxbrl_20220603181030662">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;border-collapse:collapse;width:100%;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2.30%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;100%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:15%;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:2%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="4"
      id="Fxbrl_20220603190548414_xbrl_20220603183424852"
      unitRef="Percent">0.023</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="2"
      id="Fxbrl_20220603190548417_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="2"
      id="Fxbrl_20220603190548420_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="2"
      id="Fxbrl_20220603190548423_xbrl_20220603190159494"
      unitRef="Percent">1</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="0"
      id="Fxbrl_20220603190637260"
      unitRef="Year">3</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="0"
      id="Fxbrl_20220603190548425_xbrl_20220603190209109"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="0"
      id="Fxbrl_20220603192248711"
      unitRef="CAD">260</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTwoMember"
      decimals="0"
      id="Fxbrl_20220603192636642"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="INF"
      id="Fxbrl_20220603192725027"
      unitRef="Share">9850000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="2"
      id="Fxbrl_20220603192737034"
      unitRef="CAD_per_share">0.15</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      id="Fxbrl_20220603192757314">one (1) year</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      id="Fxbrl_20220603182700232">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.47%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;135%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="4"
      id="Fxbrl_20220603190608737_xbrl_20220603183424852"
      unitRef="Percent">0.0047</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="2"
      id="Fxbrl_20220603190608739_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="2"
      id="Fxbrl_20220603190608742_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="2"
      id="Fxbrl_20220603190608744_xbrl_20220603190159494"
      unitRef="Percent">1.35</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="0"
      id="Fxbrl_20220603190642088"
      unitRef="Year">1</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="0"
      id="Fxbrl_20220603190608746_xbrl_20220603190209109"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="0"
      id="Fxbrl_20220603192808471"
      unitRef="CAD">742833</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfDirectorsOfficersAndConsultantsMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantThreeMember"
      decimals="0"
      id="Fxbrl_20220603192822298"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="INF"
      id="Fxbrl_20220603195334906"
      unitRef="Share">80000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="2"
      id="Fxbrl_20220603195348042"
      unitRef="CAD_per_share">1.02</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      id="Fxbrl_20220603195358850">five (5) years</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      id="Fxbrl_20220603182729520">
              &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;border-collapse:collapse;width:100%;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.35%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;207%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:right;vertical-align:bottom;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;34,246&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="text-align:left;vertical-align:bottom;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="4"
      id="Fxbrl_20220603190610818_xbrl_20220603183424852"
      unitRef="Percent">0.0035</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="2"
      id="Fxbrl_20220603190610819_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="2"
      id="Fxbrl_20220603190610821_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="2"
      id="Fxbrl_20220603190610823_xbrl_20220603190159494"
      unitRef="Percent">2.07</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="0"
      id="Fxbrl_20220603190647546"
      unitRef="Year">5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="0"
      id="Fxbrl_20220603190610826_xbrl_20220603190209109"
      unitRef="CAD">34246</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="0"
      id="Fxbrl_20220603195438429"
      unitRef="CAD">40603</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="0"
      id="Fxbrl_20220603195446365"
      unitRef="CAD">34246</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFiveMember"
      decimals="INF"
      id="Fxbrl_20220603195642580"
      unitRef="Share">70000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFiveMember"
      decimals="2"
      id="Fxbrl_20220603195809936"
      unitRef="CAD_per_share">0.54</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFiveMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheOneMember"
      decimals="INF"
      id="Fxbrl_20220603195552716"
      unitRef="Share">40000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFiveMember_pmedfVestingScheduleAxis_pmedfShareBasedPaymentArrangementVestingTrancheTwoMember"
      decimals="INF"
      id="Fxbrl_20220603195608781"
      unitRef="Share">30000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="INF"
      id="Fxbrl_20220603195831678"
      unitRef="Share">200000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="2"
      id="Fxbrl_20220603195847776"
      unitRef="CAD_per_share">0.54</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      id="Fxbrl_20220603182801207">
              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.26%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;189%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="4"
      id="Fxbrl_20220603190613097_xbrl_20220603183424852"
      unitRef="Percent">0.0026</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="2"
      id="Fxbrl_20220603190613098_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="2"
      id="Fxbrl_20220603190613100_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="2"
      id="Fxbrl_20220603190613102_xbrl_20220603190159494"
      unitRef="Percent">1.89</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="1"
      id="Fxbrl_20220603190652360"
      unitRef="Year">1.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="0"
      id="Fxbrl_20220603190613103_xbrl_20220603190209109"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="0"
      id="Fxbrl_20220603195904407"
      unitRef="CAD">81979</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSixMember"
      decimals="0"
      id="Fxbrl_20220603195919955"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="INF"
      id="Fxbrl_20220603200016774"
      unitRef="Share">250000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="2"
      id="Fxbrl_20220603200030181"
      unitRef="CAD_per_share">0.59</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      id="Fxbrl_20220603200045997">one (1) year</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      id="Fxbrl_20220603182950128">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.23%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;188%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;background-color:#e6efff;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;18,958&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="4"
      id="Fxbrl_20220603190615561_xbrl_20220603183424852"
      unitRef="Percent">0.0023</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="2"
      id="Fxbrl_20220603190615563_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="2"
      id="Fxbrl_20220603190615565_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="2"
      id="Fxbrl_20220603190615567_xbrl_20220603190159494"
      unitRef="Percent">1.88</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="0"
      id="Fxbrl_20220603190656895"
      unitRef="Year">1</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="0"
      id="Fxbrl_20220603190615569_xbrl_20220603190209109"
      unitRef="CAD">18958</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="0"
      id="Fxbrl_20220603200054351"
      unitRef="CAD">77375</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="0"
      id="Fxbrl_20220603200104086"
      unitRef="CAD">18958</pmedf:UnvestedStockBasedCompensationExpense>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603200146747"
      unitRef="CAD">53204</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="0"
      id="Fxbrl_20220603200301739"
      unitRef="CAD">34246</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantFourMember"
      decimals="0"
      id="Fxbrl_20220603200341603"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="0"
      id="Fxbrl_20220603200408354"
      unitRef="CAD">18958</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantSevenMember"
      decimals="0"
      id="Fxbrl_20220603200430633"
      unitRef="CAD">0</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="INF"
      id="Fxbrl_20220603200456498"
      unitRef="Share">250000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="2"
      id="Fxbrl_20220603200505382"
      unitRef="CAD_per_share">0.36</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      id="Fxbrl_20220603200523244">one (1) year</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      id="Fxbrl_20220603183054864">
              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.26%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;134.3%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,834&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="4"
      id="Fxbrl_20220603190618377_xbrl_20220603183424852"
      unitRef="Percent">0.0026</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="2"
      id="Fxbrl_20220603190618378_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="2"
      id="Fxbrl_20220603190618380_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="3"
      id="Fxbrl_20220603190618382_xbrl_20220603190159494"
      unitRef="Percent">1.343</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="0"
      id="Fxbrl_20220603190703185"
      unitRef="Year">1</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="0"
      id="Fxbrl_20220603190618384_xbrl_20220603190209109"
      unitRef="CAD">1834</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="0"
      id="Fxbrl_20220603202145921"
      unitRef="CAD">50675</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantEightMember"
      decimals="0"
      id="Fxbrl_20220603200619189"
      unitRef="CAD">1834</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="INF"
      id="Fxbrl_20220603200825579"
      unitRef="Share">250000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="3"
      id="Fxbrl_20220603200752112"
      unitRef="CAD_per_share">0.345</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      id="Fxbrl_20220603201044056">18 months</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      id="Fxbrl_20220603183120630">
              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.32%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;146.38%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,778&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="4"
      id="Fxbrl_20220603190621025_xbrl_20220603183424852"
      unitRef="Percent">0.0032</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="2"
      id="Fxbrl_20220603190621027_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="2"
      id="Fxbrl_20220603190621029_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="4"
      id="Fxbrl_20220603190621032_xbrl_20220603190159494"
      unitRef="Percent">1.4638</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="1"
      id="Fxbrl_20220603190707561"
      unitRef="Year">1.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="0"
      id="Fxbrl_20220603190621034_xbrl_20220603190209109"
      unitRef="CAD">6778</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="0"
      id="Fxbrl_20220603202156440"
      unitRef="CAD">48672</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantNineMember"
      decimals="0"
      id="Fxbrl_20220603201108792"
      unitRef="CAD">6778</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="INF"
      id="Fxbrl_20220603202327177"
      unitRef="Share">250000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="2"
      id="Fxbrl_20220603202339624"
      unitRef="CAD_per_share">0.25</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      id="Fxbrl_20220603202352319">18 months</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      id="Fxbrl_20220603183138278">
              &lt;table cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.38%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected dividends&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected forfeiture rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;131.33%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.5 years&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested stock-based compensation expense as of January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;width:1%;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;7,826&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="4"
      id="Fxbrl_20220603190623881_xbrl_20220603183424852"
      unitRef="Percent">0.0038</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="2"
      id="Fxbrl_20220603190623883_xbrl_20220603190152389"
      unitRef="Percent">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="2"
      id="Fxbrl_20220603190623885_xbrl_20220603190156319"
      unitRef="Percent">0</pmedf:DescriptionOfExpectedForfeitureRateShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="4"
      id="Fxbrl_20220603190623887_xbrl_20220603190159494"
      unitRef="Percent">1.3133</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="1"
      id="Fxbrl_20220603190712488"
      unitRef="Year">1.5</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="0"
      id="Fxbrl_20220603190623889_xbrl_20220603190209109"
      unitRef="CAD">7826</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="0"
      id="Fxbrl_20220603202409287"
      unitRef="CAD">30445</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_pmedfConsultantMember_pmedfStockOptionsGrantAxis_pmedfStockOptionsGrantTenMember"
      decimals="0"
      id="Fxbrl_20220603202420016"
      unitRef="CAD">7826</pmedf:UnvestedStockBasedCompensationExpense>
    <pmedf:UnvestedStockBasedCompensationExpense
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603202509271"
      unitRef="CAD">16438</pmedf:UnvestedStockBasedCompensationExpense>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603183217728">
            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of&lt;br/&gt;Options&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;350,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;10,450,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(250,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,455,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.15&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;9,095,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.18&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;750,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.32&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(4,776,250&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(3,968,750&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.15&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.42&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20200131"
      decimals="INF"
      id="Fxbrl_20220603212624962"
      unitRef="Share">350000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20200131"
      decimals="2"
      id="Fxbrl_20220603212838898"
      unitRef="CAD_per_share">0.1</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603212703098"
      unitRef="Share">10450000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20200201to20210131"
      decimals="2"
      id="Fxbrl_20220603212928906"
      unitRef="CAD_per_share">0.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603212721659"
      unitRef="Share">250000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="C_20200201to20210131"
      decimals="2"
      id="Fxbrl_20220603212948114"
      unitRef="CAD_per_share">0.1</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603212726162"
      unitRef="Share">1455000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20200201to20210131"
      decimals="2"
      id="Fxbrl_20220603212951754"
      unitRef="CAD_per_share">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20210131"
      decimals="INF"
      id="Fxbrl_20220603212636179"
      unitRef="Share">9095000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20210131"
      decimals="2"
      id="Fxbrl_20220603212858042"
      unitRef="CAD_per_share">0.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603212751851"
      unitRef="Share">750000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603213030122"
      unitRef="CAD_per_share">0.32</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603212800466"
      unitRef="Share">4776250</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603213048611"
      unitRef="CAD_per_share">0.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603212810890"
      unitRef="Share">3968750</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603213121017"
      unitRef="CAD_per_share">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220603212648450"
      unitRef="Share">1100000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20220131"
      decimals="2"
      id="Fxbrl_20220603212901434"
      unitRef="CAD_per_share">0.42</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220614115435977">
              &lt;div&gt;
                &lt;div style="margin-bottom:16px"&gt;
                  &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercisable&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Remaining Life&lt;br/&gt;(Years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;80,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.46&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;July 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;70,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.11&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 10, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 30, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;187,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 23, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 9, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;July 30, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;780,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$0.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.86&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:20%;vertical-align:top;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyOneSevenTwoZeroTwoFiveMember"
      decimals="INF"
      id="Fxbrl_20220603214212863_xbrl_20220603213458051"
      unitRef="Share">80000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyOneSevenTwoZeroTwoFiveMember"
      decimals="INF"
      id="Fxbrl_20220603214212863_xbrl_20220603213617637"
      unitRef="Share">80000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyOneSevenTwoZeroTwoFiveMember"
      decimals="2"
      id="Fxbrl_20220603214212863_xbrl_20220603213710726"
      unitRef="CAD_per_share">1.02</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyOneSevenTwoZeroTwoFiveMember"
      id="Fxbrl_20220603214212863_xbrl_20220603213806798">P3Y5M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <pmedf:ExpiryDateOfOutstandingShareOptions
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyOneSevenTwoZeroTwoFiveMember"
      id="Fxbrl_20220603214424124">July 17, 2025</pmedf:ExpiryDateOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchOneZeroTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212867_xbrl_20220603213504704"
      unitRef="Share">70000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchOneZeroTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212867_xbrl_20220603213635926"
      unitRef="Share">0</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchOneZeroTwoZeroTwoTwoMember"
      decimals="2"
      id="Fxbrl_20220603214212867_xbrl_20220603213729950"
      unitRef="CAD_per_share">0.54</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchOneZeroTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214212867_xbrl_20220603213840718">P0Y1M9D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <pmedf:ExpiryDateOfOutstandingShareOptions
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchOneZeroTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214437867">March 10, 2022</pmedf:ExpiryDateOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchThreeZeroTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212873_xbrl_20220603213508070"
      unitRef="Share">200000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchThreeZeroTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212873_xbrl_20220603213639941"
      unitRef="Share">200000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchThreeZeroTwoZeroTwoTwoMember"
      decimals="2"
      id="Fxbrl_20220603214212873_xbrl_20220603213733158"
      unitRef="CAD_per_share">0.54</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchThreeZeroTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214212873_xbrl_20220603213844149">P0Y2M1D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <pmedf:ExpiryDateOfOutstandingShareOptions
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchThreeZeroTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214449043">March 30, 2022</pmedf:ExpiryDateOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchTwoThreeTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212878_xbrl_20220603213511742"
      unitRef="Share">250000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchTwoThreeTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212878_xbrl_20220603213646949"
      unitRef="Share">187500</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchTwoThreeTwoZeroTwoTwoMember"
      decimals="2"
      id="Fxbrl_20220603214212878_xbrl_20220603213736245"
      unitRef="CAD_per_share">0.36</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchTwoThreeTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214212878_xbrl_20220603213847295">P0Y1M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <pmedf:ExpiryDateOfOutstandingShareOptions
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireMarchTwoThreeTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214457523">March 23, 2022</pmedf:ExpiryDateOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireDecemberNineTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212882_xbrl_20220603213515520"
      unitRef="Share">250000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireDecemberNineTwoZeroTwoTwoMember"
      decimals="INF"
      id="Fxbrl_20220603214212882_xbrl_20220603213651949"
      unitRef="Share">125000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireDecemberNineTwoZeroTwoTwoMember"
      decimals="2"
      id="Fxbrl_20220603214212882_xbrl_20220603213739533"
      unitRef="CAD_per_share">0.35</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireDecemberNineTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214212882_xbrl_20220603213852582">P0Y10M9D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <pmedf:ExpiryDateOfOutstandingShareOptions
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireDecemberNineTwoZeroTwoTwoMember"
      id="Fxbrl_20220603214505907">December 9, 2022</pmedf:ExpiryDateOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyThreeZeroTwoZeroTwoThreeMember"
      decimals="INF"
      id="Fxbrl_20220603214212887_xbrl_20220603213519310"
      unitRef="Share">250000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyThreeZeroTwoZeroTwoThreeMember"
      decimals="INF"
      id="Fxbrl_20220603214212887_xbrl_20220603213656165"
      unitRef="Share">125000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="C_20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyThreeZeroTwoZeroTwoThreeMember"
      decimals="2"
      id="Fxbrl_20220603214212887_xbrl_20220603213744445"
      unitRef="CAD_per_share">0.25</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyThreeZeroTwoZeroTwoThreeMember"
      id="Fxbrl_20220603214212887_xbrl_20220603213856229">P1Y6M</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <pmedf:ExpiryDateOfOutstandingShareOptions
      contextRef="C_20210201to20220131_pmedfOptionsOutstandingByExpirationDateAxis_pmedfExpireJulyThreeZeroTwoZeroTwoThreeMember"
      id="Fxbrl_20220603214514083">July 30, 2023</pmedf:ExpiryDateOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220603214212893_xbrl_20220603213522790"
      unitRef="Share">1100000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220603214212893_xbrl_20220603213700086"
      unitRef="Share">780000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="C_20220131"
      decimals="2"
      id="Fxbrl_20220603214212893_xbrl_20220603213748397"
      unitRef="CAD_per_share">0.42</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603214212893_xbrl_20220603213900268">P0Y10M9D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603152156079">
      &lt;div&gt;
        &lt;p style="text-align:justify;text-indent:-22pt;margin-left:22pt;margin-top:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;11.&lt;/strong&gt;&lt;span style="width:9.5pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Capital Stock&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company is authorized to issue the following shares:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;ul style="padding-left:0pt;list-style-type:disc"&gt;
          &lt;li style="margin-left:36.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unlimited number of common shares without par value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
        &lt;/ul&gt;
        &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;a)&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Common shares&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The holders of common shares are entitled to receive dividends which are declared from time to time and are entitled to one vote per share at meetings of the Company. All shares are ranked equally with regards to the Company's residual assets.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;At January 31, 2022, the Company has 109,051,292 common shares issued and outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;b)&lt;/strong&gt;&lt;span style="width:13.5pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Share issuances&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="text-indent:27pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;During the year ended January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;ul style="padding-left:0pt;list-style-type:disc"&gt;
          &lt;li style="margin-left:18.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On March 5, 2021, the Company closed a private placement of 3,114,569 units at $0.35 per unit for a consideration of $1,090,085. Each unit is comprised of one common share and one common share purchase warrant, with each warrant exercisable into a common share of the Company at an exercise price of $0.50 per share for a period of 24 months. The Black-Scholes option pricing model was used to determine the fair value of the warrants using the following weight average assumptions: Expected dividend yield of 0%; risk free interest rate of 0.29%; expected volatility of 131%; expected life of 2 years. The relative fair value of the warrants has been valued at $394,681 and common shares at $695,404. In connection with this private placement, the Company incurred $3,770 in share issuance costs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
          &lt;li style="margin-left:18.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,968,750 shares were issued upon exercise of 3,968,750 options at a price of $0.15 per share for total gross proceeds of $595,313. An amount of $361,284 was reclassed from share-based payment reserve to share capital.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
          &lt;li style="margin-left:18.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;250,000 shares were fair valued at $36,250 and issued for services.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
        &lt;/ul&gt;
        &lt;div/&gt;
        &lt;p style="text-indent:27pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;During the year ended January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;ul style="padding-left:0pt;list-style-type:disc"&gt;
          &lt;li style="margin-left:18.6pt;padding-left:8.4pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company cancelled 4,000,000 common shares pursuant to the sale of its interest in Cultivar JA (Note 5).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
          &lt;li style="margin-left:18.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,355,000 shares were issued upon exercise of 1,355,000 options at a price of $0.15 per share and 100,000 shares were issued upon exercise of 100,000 options at a price of $0.10 per share for total gross proceeds of $213,250. An amount of $108,435 was reclassed from share-based payment reserve to share capital.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
          &lt;li style="margin-left:18.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;100,000 shares were issued upon exercise of 100,000 warrants at a price of $0.50 per share for gross proceeds of $50,000. An amount of $7,481 was reclassed from warrant reserve to share capital.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
          &lt;li style="margin-left:18.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;50,000 shares were issued pursuant to the acquisition of MobileWellbeing ("MWB"), an innovative, feature rich, Telemedicine Remote Patient Monitoring platform (Note 8)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
          &lt;li style="margin-left:18.6pt;text-align:justify;padding-left:8.4pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;58,824 shares were issued at a price of $0.34 for a total consideration of $20,000. $8,333 was expensed to consulting services during the year ended January 31, 2021, while the remaining $11,667 is included in prepaid expenses as at January 31, 2021. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/li&gt;
        &lt;/ul&gt;
        &lt;p style="margin-left:44pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;c)&lt;/strong&gt;&lt;span style="width:14pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Warrants &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Continuity of the Company's warrants is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-left:22pt"&gt;

            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,648,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(100,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,548,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,114,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,548,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,114,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As at January 31, 2022, the Company had the following warrants outstanding:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-left:22pt"&gt;

            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                &lt;tr&gt;
                  &lt;td style="width:25%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Remaining Life (Years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,114,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 5, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_202206032102562980"
      unitRef="Shares">109051292</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220603210256298"
      unitRef="Shares">109051292</ifrs-full:NumberOfSharesIssued>
    <pmedf:NumberOfUnitsIssued
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603210831949"
      unitRef="Shares">3114569</pmedf:NumberOfUnitsIssued>
    <pmedf:UnitsIssuedPricePerUnit
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603210853083"
      unitRef="CAD_per_share">0.35</pmedf:UnitsIssuedPricePerUnit>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603210859369"
      unitRef="CAD">1090085</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019
      contextRef="C_20220131"
      decimals="2"
      id="Fxbrl_20220603211011731"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019>
    <pmedf:TermOfWarrants
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603211140747">P24M</pmedf:TermOfWarrants>
    <pmedf:ExpectedDividendYieldOfWarrantsGranted
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603211209285"
      unitRef="Percent">0</pmedf:ExpectedDividendYieldOfWarrantsGranted>
    <pmedf:RiskFreeInterestRateWarrantsGranted
      contextRef="C_20210201to20220131"
      decimals="4"
      id="Fxbrl_20220603211228723"
      unitRef="Percent">0.0029</pmedf:RiskFreeInterestRateWarrantsGranted>
    <pmedf:ExpectedVolatilityOfWarransGranted
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603211232423"
      unitRef="Percent">1.31</pmedf:ExpectedVolatilityOfWarransGranted>
    <pmedf:ExpectedLifeOfWarrantsGranted
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603211444105">P2Y</pmedf:ExpectedLifeOfWarrantsGranted>
    <pmedf:FairValueOfWarrantsIssued
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603211243813"
      unitRef="CAD">394681</pmedf:FairValueOfWarrantsIssued>
    <pmedf:FairValueOfCommonSharesIssued
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603211247497"
      unitRef="CAD">695404</pmedf:FairValueOfCommonSharesIssued>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603211256040"
      unitRef="CAD">3770</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220608115714854"
      unitRef="Share">3968750</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603211729974"
      unitRef="Share">3968750</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603211735436"
      unitRef="CAD_per_share">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603211740486"
      unitRef="CAD">595313</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20210201to20220131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603211744088"
      unitRef="CAD">-361284</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603211748213"
      unitRef="Shares">250000</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares>
    <pmedf:FairValueOfSharesIssuedForServices
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603211752017"
      unitRef="CAD">36250</pmedf:FairValueOfSharesIssuedForServices>
    <pmedf:NumberOfCommonSharesCancelled
      contextRef="C_20200201to20210131_ifrsfullSignificantInvestmentsInSubsidiariesAxis_pmedfSubsidiariesTwoMember"
      decimals="INF"
      id="Fxbrl_20220603212102232"
      unitRef="Shares">4000000</pmedf:NumberOfCommonSharesCancelled>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseOneMember"
      decimals="INF"
      id="Fxbrl_20220608115706655"
      unitRef="Share">1355000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseOneMember"
      decimals="INF"
      id="Fxbrl_20220603212329491"
      unitRef="Share">1355000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseOneMember"
      decimals="2"
      id="Fxbrl_20220603212406139"
      unitRef="CAD_per_share">0.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseTwoMember"
      decimals="0"
      id="Fxbrl_20220608155453433"
      unitRef="Share">100000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseTwoMember"
      decimals="0"
      id="Fxbrl_20220603212801613"
      unitRef="Share">100000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="C_20200201to20210131_pmedfOptionExerciseAxis_pmedfOptionExerciseTwoMember"
      decimals="2"
      id="Fxbrl_20220603212808702"
      unitRef="CAD_per_share">0.1</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603212913994"
      unitRef="CAD">213250</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fxbrl_20220603212941412"
      unitRef="CAD">-108435</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220608115732008"
      unitRef="Share">100000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603213226001"
      unitRef="Share">100000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="C_20200201to20210131"
      decimals="2"
      id="Fxbrl_20220603213228803"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603213314663"
      unitRef="CAD">50000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20200201to20210131_ifrsfullComponentsOfEquityAxis_ifrsfullWarrantReserveMember"
      decimals="0"
      id="Fxbrl_20220603213754542"
      unitRef="CAD">-7481</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <pmedf:SharesIssuedToAcquireIntangibleAssetsIncludingClosing
      contextRef="C_20200201to20210131_ifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_pmedfMobilewellbeingMember"
      decimals="INF"
      id="Fxbrl_20220603213758978"
      unitRef="Shares">50000</pmedf:SharesIssuedToAcquireIntangibleAssetsIncludingClosing>
    <pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603213856561"
      unitRef="Shares">58824</pmedf:IncreaseDecreaseThroughSharesIssuedForConsultingServicesShares>
    <pmedf:SharesIssuedPricePerShare
      contextRef="C_20200201to20210131"
      decimals="2"
      id="Fxbrl_20220603213905694"
      unitRef="CAD_per_share">0.34</pmedf:SharesIssuedPricePerShare>
    <pmedf:ConsiderationFromSharesIssued
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603213909425"
      unitRef="CAD">20000</pmedf:ConsiderationFromSharesIssued>
    <pmedf:ConsiderationFromSharesIssuedExpensedToConsultingServices
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603213912623"
      unitRef="CAD">8333</pmedf:ConsiderationFromSharesIssuedExpensedToConsultingServices>
    <pmedf:ConsiderationFromSharesIssuedIncludedInPrepaidExpenses
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603214103516"
      unitRef="CAD">11667</pmedf:ConsiderationFromSharesIssuedIncludedInPrepaidExpenses>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603152221696">
            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Number of Warrants&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Weighted Average Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,648,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(100,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,548,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Issued&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,114,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,548,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Outstanding, January 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,114,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20200131"
      decimals="INF"
      id="Fxbrl_20220603152750061_12"
      unitRef="Share">1648000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20200131"
      decimals="2"
      id="Fxbrl_20220603152750061_15"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="C_20200201to20210131"
      decimals="INF"
      id="Fxbrl_20220603152750061_22"
      unitRef="Share">100000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
      contextRef="C_20200201to20210131"
      decimals="2"
      id="Fxbrl_20220603152750061_25"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20210131"
      decimals="INF"
      id="Fxbrl_20220603152750061_32"
      unitRef="Share">1548000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20210131"
      decimals="2"
      id="Fxbrl_20220603152750061_35"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603152750061_42"
      unitRef="Share">3114569</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603152750061_45"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
      contextRef="C_20210201to20220131"
      decimals="INF"
      id="Fxbrl_20220603152750061_52"
      unitRef="Share">1548000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement2019
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603152750061_55"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220603152750061_62"
      unitRef="Share">3114569</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20220131"
      decimals="2"
      id="Fxbrl_20220603152750061_65"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <pmedf:DisclosureOfNumberExercisePriceAndRemainingContractualLifeOfOutstandingWarrantsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603152235743">
            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt"&gt;

                &lt;tr&gt;
                  &lt;td style="width:25%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Outstanding&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Exercise Price&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Remaining Life (Years)&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,114,569&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.50&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:25%;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;March 5, 2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </pmedf:DisclosureOfNumberExercisePriceAndRemainingContractualLifeOfOutstandingWarrantsExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="C_20220131"
      decimals="INF"
      id="Fxbrl_20220603154359754"
      unitRef="Share">3114569</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019
      contextRef="C_20220131"
      decimals="2"
      id="Fxbrl_20220603154403176"
      unitRef="CAD_per_share">0.5</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
    <pmedf:WeightedAverageRemainingContractualLifeOfOutstandingWarrants
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603154350719_12">P1Y1M2D</pmedf:WeightedAverageRemainingContractualLifeOfOutstandingWarrants>
    <pmedf:ExpiryDateOfOutstandingWarrants
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603154407592">2023-03-05</pmedf:ExpiryDateOfOutstandingWarrants>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603115544872">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify;margin-top:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;12.&lt;/strong&gt;&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Related Party Transactions &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Related parties include key management personnel, the Board of Directors, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions. Key management of the Company are members of the Board of Directors, the Chief Executive Officer ("CEO"), the Chief Financial Officer ("CFO") and the Chief Operating Officer ("COO").&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Transactions with key management personnel not disclosed elsewhere in the financial statements include the following:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Year ended&#160;&lt;br/&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Year ended&lt;br/&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to the CEO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;109,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;99,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to a prior director&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to the COO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;92,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;68,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to the CFO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;68,345&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;43,550&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Total Management fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;269,845&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;217,050&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Vehicle expense to the CEO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Vehicle expenses to the COO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Rent to the CEO included in rent expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;28,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;border-bottom:2.25pt double #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;334,345&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;261,050&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;During the year ended January 31, 2022, the Company paid $127,000 (January 31, 2021: $61,329) being marketing expenses to companies controlled by the children of the CEO.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;As of January 31, 2022, there was $nil due to any related parties (January 31, 2021- $nil). During the year ended January 31, 2022, there was $12,995 advanced to the CEO to meet Company expenses (2021: $12,995) and included in prepaid expenses.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603115558186">
              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Year ended&#160;&lt;br/&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right;white-space:nowrap"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Year ended&lt;br/&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to the CEO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;109,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;99,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to a prior director&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;6,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to the COO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;92,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;68,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Management fees to the CFO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;68,345&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;43,550&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Total Management fees&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;269,845&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;217,050&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Vehicle expense to the CEO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;12,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Vehicle expenses to the COO&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;18,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;10,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;Rent to the CEO included in rent expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;28,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;21,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;border-bottom:2.25pt double #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;334,345&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;261,050&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <pmedf:ManagementFees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_22"
      unitRef="CAD">109500</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_25"
      unitRef="CAD">99500</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtDirectorMember"
      decimals="0"
      id="Fxbrl_20220603115611287_32"
      unitRef="CAD">0</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtDirectorMember"
      decimals="0"
      id="Fxbrl_20220603115611287_35"
      unitRef="CAD">6000</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_42"
      unitRef="CAD">92000</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_45"
      unitRef="CAD">68000</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefFinancialOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_52"
      unitRef="CAD">68345</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefFinancialOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_55"
      unitRef="CAD">43550</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603115611287_62"
      unitRef="CAD">269845</pmedf:ManagementFees>
    <pmedf:ManagementFees
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603115611287_65"
      unitRef="CAD">217050</pmedf:ManagementFees>
    <pmedf:VehicleExpenseKeyManagementPersonnel
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_72"
      unitRef="CAD">18000</pmedf:VehicleExpenseKeyManagementPersonnel>
    <pmedf:VehicleExpenseKeyManagementPersonnel
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_75"
      unitRef="CAD">12000</pmedf:VehicleExpenseKeyManagementPersonnel>
    <pmedf:VehicleExpenseKeyManagementPersonnel
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_82"
      unitRef="CAD">18000</pmedf:VehicleExpenseKeyManagementPersonnel>
    <pmedf:VehicleExpenseKeyManagementPersonnel
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_85"
      unitRef="CAD">10500</pmedf:VehicleExpenseKeyManagementPersonnel>
    <ifrs-full:RentalExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_92"
      unitRef="CAD">28500</ifrs-full:RentalExpense>
    <ifrs-full:RentalExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115611287_95"
      unitRef="CAD">21500</ifrs-full:RentalExpense>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603115611287_102"
      unitRef="CAD">334345</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603115611287_105"
      unitRef="CAD">261050</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20210201to20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603115901024"
      unitRef="CAD">127000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20200201to20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603120835488"
      unitRef="CAD">61329</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603120853216"
      unitRef="CAD">0</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603120917336"
      unitRef="CAD">0</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="C_20220131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603120933416"
      unitRef="CAD">12995</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="C_20210131_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603120950127"
      unitRef="CAD">12995</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603133258133">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;13.&lt;/strong&gt;&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Commitments and Contingencies&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective July 1, 2020, the Company signed a two-year contract with a corporation owned and controlled by the CEO to pay monthly compensation of $8,500 for CEO services which effective September 1, 2021 was revised to $10,000 per month. In addition, the Company is obligated to pay monthly rent for $2,000 and an additional $1,500 for the use of a personal vehicle.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Effective July 1, 2020, the Company signed a two-year contract with a corporation owned and controlled by the COO to pay monthly compensation of $6,000 for COO services which effective May 1, 2021, is revised to $8,500 per month. In addition, the Company is obligated to pay an additional $1,500 for the use of a personal vehicle.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <pmedf:MonthlyCompensation
      contextRef="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603155855676"
      unitRef="CAD">8500</pmedf:MonthlyCompensation>
    <pmedf:RevisedMonthlyCompensation
      contextRef="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603155908498"
      unitRef="CAD">10000</pmedf:RevisedMonthlyCompensation>
    <pmedf:MonthlyRentObligation
      contextRef="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603155912062"
      unitRef="CAD">2000</pmedf:MonthlyRentObligation>
    <pmedf:PersonalVehicleObligation
      contextRef="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefExecutiveOfficerMember"
      decimals="0"
      id="Fxbrl_20220603155914729"
      unitRef="CAD">1500</pmedf:PersonalVehicleObligation>
    <pmedf:MonthlyCompensation
      contextRef="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember"
      decimals="0"
      id="Fxbrl_20220603155919841"
      unitRef="CAD">6000</pmedf:MonthlyCompensation>
    <pmedf:RevisedMonthlyCompensation
      contextRef="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember"
      decimals="0"
      id="Fxbrl_20220603155922971"
      unitRef="CAD">8500</pmedf:RevisedMonthlyCompensation>
    <pmedf:PersonalVehicleObligation
      contextRef="C_20200731_ifrsfullCategoriesOfRelatedPartiesAxis_srtChiefOperatingOfficerMember"
      decimals="0"
      id="Fxbrl_20220603155927194"
      unitRef="CAD">1500</pmedf:PersonalVehicleObligation>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603125938648">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;14.&lt;/strong&gt;&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Financial Instruments&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of the Company's accounts receivables and accounts payable, approximate carrying value, due to their short-term nature. The Company's cash is measured at fair value under the fair value hierarchy based on level one quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;Financial risk management and objectives&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's activities expose it to a variety of financial risks: credit risk, liquidity risk, and market risk (including interest rate risk, foreign currency risk, and commodity price risk).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company thoroughly examines the various financial risks to which it is exposed and assesses the impact and likelihood of those risks. Where material, these risks are reviewed and monitored by the Board of Directors.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Credit risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk as During the year ended January 31, 2022, one customer represented 100% of the total revenue and represented 100% of the total accounts receivable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Liquidity risk&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liquidity risk is the risk that the Company will not have sufficient cash resources to meet its financial obligations as they come due. The Company's liquidity and operating results may be adversely affected if its access to the capital market is hindered, whether as a result of a downturn in stock market conditions generally or matters specific to the Company. The Company generates cash flows primarily from its financing activities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company manages its liquidity needs by carefully monitoring scheduled costs. Liquidity is measured in various time bands, on day to day and week-to-week basis, as well as on long term liquidity needs over 180 day to 360 day look out periods. Funding for long term liquidity needs is based on the ability of the Company to successfully complete private placements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As at January 31, 2022, the Company had cash and cash equivalents of $211,302 to settle current liabilities of $349,672.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div/&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Market Risk &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Market risk is the risk of loss that may arise from changes in market factors such as interest rates, commodity and equity prices, and foreign exchange rates.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;(a)&lt;/i&gt;&lt;span style="width:5.78pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;i&gt;Interest rate risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to significant interest rate risk.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;(b)&lt;/i&gt;&lt;span style="width:5.78pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;i&gt;Price risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is not exposed to significant price risk as it does not possess investments in publicly traded securities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;i&gt;(c)&lt;/i&gt;&lt;span style="width:6.34pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;i&gt;Currency risk&lt;/i&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Currency risk is the risk that the fair value of future cash flows of a financial instrument denominated in a foreign currency will fluctuate because of changes in foreign exchange rates. Effective sale of the Company's interest in Cultivar JA in March 2020, the Company has no exposure to any currency except Canadian dollars.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="C_20210201to20220131_ifrsfullTypesOfRisksAxis_ifrsfullCreditRiskMember_srtMajorCustomersAxis_pmedfOneCustomerMember"
      decimals="2"
      id="Fxbrl_20220603143347047"
      unitRef="Percent">1</ifrs-full:PercentageOfEntitysRevenue>
    <pmedf:PercentageOfAccountsReceivable
      contextRef="C_20210201to20220131_ifrsfullTypesOfRisksAxis_ifrsfullCreditRiskMember_srtMajorCustomersAxis_pmedfOneCustomerMember"
      decimals="2"
      id="Fxbrl_20220603143400256"
      unitRef="Percent">1</pmedf:PercentageOfAccountsReceivable>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20220131_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="0"
      id="Fxbrl_20220603130016985"
      unitRef="CAD">211302</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20220131_ifrsfullTypesOfRisksAxis_ifrsfullLiquidityRiskMember"
      decimals="0"
      id="Fxbrl_20220603130021957"
      unitRef="CAD">349672</ifrs-full:CurrentLiabilities>
    <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603124831544">
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;15.&lt;/strong&gt;&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Capital Management&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company considers its capital to be shareholders' equity, which is comprised of share capital and deficit, which as at January 31, 2022 totaled $886,985. The Company's capital structure is adjusted based on the funds available to the Company such that it may continue to seek new opportunities. The Board of Directors does not establish quantitative return on capital criteria, but rather relies on the expertise of management and other professionals to sustain future development of the business.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The sources of future funds presently available to the Company are through the sale of equity capital or debt of the Company. The ability of the Company to arrange such financing in the future will depend in part upon the prevailing capital market conditions as well as the business performance of the Company. There can be no assurance that the Company will be successful in its efforts to arrange additional financing, if needed, on terms satisfactory to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the Company, is reasonable. The Company is not subject to externally imposed capital restrictions.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/div&gt;
      </ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory>
    <ifrs-full:Equity
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603124847509"
      unitRef="CAD">886985</ifrs-full:Equity>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603143802045">
    &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;16.&lt;/strong&gt;&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Business Segment and Concentration&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company, through its subsidiaries, is currently focused on artificial intelligence ("AI") technologies which are targeting two specific areas: 1) workplace health and safety and 2) healthcare. All assets are located in Canada except property and equipment for $76,255 which is located in India.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the year ended January 31, 2022, one customer represented 100% of the total revenue and represented 100% of the total accounts receivable.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220131_srtStatementGeographicalAxis_countryIN"
      decimals="0"
      id="Fxbrl_20220603143436622"
      unitRef="CAD">76255</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="C_20210201to20220131_ifrsfullTypesOfRisksAxis_ifrsfullCreditRiskMember_srtMajorCustomersAxis_pmedfOneCustomerMember"
      decimals="2"
      id="Fxbrl_20220603143605205"
      unitRef="Percent">1</ifrs-full:PercentageOfEntitysRevenue>
    <pmedf:PercentageOfAccountsReceivable
      contextRef="C_20210201to20220131_ifrsfullTypesOfRisksAxis_ifrsfullCreditRiskMember_srtMajorCustomersAxis_pmedfOneCustomerMember"
      decimals="2"
      id="Fxbrl_20220603143610512"
      unitRef="Percent">1</pmedf:PercentageOfAccountsReceivable>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603122804192">
      &lt;div&gt;
        &lt;div&gt;
          &lt;p style="margin-left:22pt;text-indent:-22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;17.&lt;/strong&gt;&lt;span style="width:9pt;text-indent:0pt;display:inline-block"&gt;&#160;&lt;/span&gt;&lt;strong&gt;Income Taxes&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The following is a reconciliation of income taxes attributable to operations computed at the statutory tax rates to income tax recovery.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Loss for the period&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,882,178&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,584,533&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Tax rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;27%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;27%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected income tax recoverable at statutory rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(508,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(428,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Change due to acquisition, tax rates, and other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(32,131&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-deductible items&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;54,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;166,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(26,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;350,282&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Change in unrecognized deductible temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;455,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(30,151&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total income tax recovery&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
          &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The significant components of the Company's deferred tax assets that have not been included on the consolidated statement of financial position are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
          &lt;div style="margin-left:22pt"&gt;

              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-capital losses available for future period&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,821,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,381,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;19,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Property equipment and intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,856,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,401,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Less: Unrecognized deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,856,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,401,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;

          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div/&gt;
        &lt;p style="margin-left:22pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The significant components of the Company's unrecognized temporary differences and tax losses are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;div style="margin-left:22pt"&gt;

            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,745,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2027 - 2042&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,116,666&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2042 - 2046&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;69,003&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;border-bottom:2.25pt double #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property equipment and intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;84,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;No expiry&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,180&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;p style="margin-left:22pt;text-align:justify;margin-top:10pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Tax attributes are subject to review and potential adjustment by tax authorities.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
    </ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <pmedf:DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603122731007">
              &lt;table cellspacing="0" style="border-collapse:collapse;font-size:10pt;width:100%;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Loss for the period&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,882,178&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,584,533&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Tax rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;27%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;27%&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected income tax recoverable at statutory rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(508,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(428,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Change due to acquisition, tax rates, and other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(32,131&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-deductible items&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;54,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;166,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(26,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expired non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;350,282&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:0.75pt solid #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Change in unrecognized deductible temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;455,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(30,151&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total income tax recovery&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </pmedf:DisclosureOfDetailedInformationAboutReconciliationOfProvisionForIncomeTaxesExplanatory>
    <ifrs-full:AccountingProfit
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_12"
      unitRef="CAD">-1882178</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_15"
      unitRef="CAD">-1584533</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20210201to20220131"
      decimals="2"
      id="Fxbrl_20220603104545388_22"
      unitRef="Percent">0.27</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="C_20200201to20210131"
      decimals="2"
      id="Fxbrl_20220603104545388_25"
      unitRef="Percent">0.27</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_32"
      unitRef="CAD">-508000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_35"
      unitRef="CAD">-428000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <pmedf:TaxEffectOfChangeDueToAcquisitionTaxRatesAndOther
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_42"
      unitRef="CAD">0</pmedf:TaxEffectOfChangeDueToAcquisitionTaxRatesAndOther>
    <pmedf:TaxEffectOfChangeDueToAcquisitionTaxRatesAndOther
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_45"
      unitRef="CAD">-32131</pmedf:TaxEffectOfChangeDueToAcquisitionTaxRatesAndOther>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_52"
      unitRef="CAD">54000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_55"
      unitRef="CAD">166000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <pmedf:TaxEffectOfShareIssuanceCosts
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_62"
      unitRef="CAD">-1000</pmedf:TaxEffectOfShareIssuanceCosts>
    <pmedf:TaxEffectOfShareIssuanceCosts
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_65"
      unitRef="CAD">-26000</pmedf:TaxEffectOfShareIssuanceCosts>
    <pmedf:TaxEffectOfExpiredNonCapitalLosses
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_72"
      unitRef="CAD">0</pmedf:TaxEffectOfExpiredNonCapitalLosses>
    <pmedf:TaxEffectOfExpiredNonCapitalLosses
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_75"
      unitRef="CAD">350282</pmedf:TaxEffectOfExpiredNonCapitalLosses>
    <pmedf:TaxEffectOfChangeInUnrecognizedDeductibleTemporaryDifferences
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_82"
      unitRef="CAD">455000</pmedf:TaxEffectOfChangeInUnrecognizedDeductibleTemporaryDifferences>
    <pmedf:TaxEffectOfChangeInUnrecognizedDeductibleTemporaryDifferences
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_85"
      unitRef="CAD">-30151</pmedf:TaxEffectOfChangeInUnrecognizedDeductibleTemporaryDifferences>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20210201to20220131"
      decimals="0"
      id="Fxbrl_20220603104545388_92"
      unitRef="CAD">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20200201to20210131"
      decimals="0"
      id="Fxbrl_20220603104545388_95"
      unitRef="CAD">0</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603122742327">
              &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Non-capital losses available for future period&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,821,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,381,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;13,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;19,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Property equipment and intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;22,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:justify;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,856,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,401,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-top:0.75pt solid #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Less: Unrecognized deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,856,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,401,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:0.75pt solid #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-bottom:2.25pt double #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            </ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20220131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember"
      decimals="0"
      id="Fxbrl_20220603111508664"
      unitRef="CAD">1821000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20210131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember"
      decimals="0"
      id="Fxbrl_20220603111520890"
      unitRef="CAD">1381000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20220131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfShareIssuanceCostsMember"
      decimals="0"
      id="Fxbrl_20220603111550138_xbrl_20220603111508664"
      unitRef="CAD">13000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20210131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfShareIssuanceCostsMember"
      decimals="0"
      id="Fxbrl_20220603111550138_xbrl_20220603111520890"
      unitRef="CAD">19000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20220131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember"
      decimals="0"
      id="Fxbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111508664"
      unitRef="CAD">22000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20210131_pmedfComponentsOfDeferredTaxAssetsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember"
      decimals="0"
      id="Fxbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111520890"
      unitRef="CAD">1000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603111648666_xbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111508664"
      unitRef="CAD">1856000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603111648666_xbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111520890"
      unitRef="CAD">1401000</ifrs-full:DeferredTaxAssets>
    <pmedf:UnrecognizedDeferredTaxAssets
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603111707292_xbrl_20220603111648666_xbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111508664"
      unitRef="CAD">1856000</pmedf:UnrecognizedDeferredTaxAssets>
    <pmedf:UnrecognizedDeferredTaxAssets
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603111707292_xbrl_20220603111648666_xbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111520890"
      unitRef="CAD">1401000</pmedf:UnrecognizedDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="C_20220131"
      decimals="0"
      id="Fxbrl_20220603111807637_xbrl_20220603111707292_xbrl_20220603111648666_xbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111508664"
      unitRef="CAD">0</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="C_20210131"
      decimals="0"
      id="Fxbrl_20220603111807637_xbrl_20220603111707292_xbrl_20220603111648666_xbrl_20220603111625178_xbrl_20220603111550138_xbrl_20220603111520890"
      unitRef="CAD">0</ifrs-full:NetDeferredTaxAssets>
    <pmedf:DisclosureOfDetailedInformationAboutUnrecognizedTemporaryDifferencesAndTaxLossesExplanatory
      contextRef="C_20210201to20220131"
      id="Fxbrl_20220603122753983">
            &lt;table cellspacing="0" style="width:100%;border-collapse:collapse;font-size:10pt;border-color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2022&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;Expiry Date&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid rgb(0, 0, 0);border-bottom:0.75pt solid rgb(0, 0, 0);white-space:nowrap;text-align:right"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;January 31, 2021&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-top:1.5pt solid #000000;border-bottom:0.75pt solid #000000;text-align:center"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;text-align:justify;background-color:#e6efff;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Non-capital losses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,745,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2027 - 2042&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,116,666&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Share issuance costs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;47,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2042 - 2046&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:1%"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:right;width:15%"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;69,003&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;text-align:left;width:2%"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="margin-top:0pt;margin-bottom:0pt;vertical-align:bottom;background-color:#e6efff;border-bottom:2.25pt double #000000;padding-left:5pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Property equipment and intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;84,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;No expiry&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:1%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:right;width:15%;background-color:#e6efff"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,180&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:left;width:2%;background-color:#e6efff"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </pmedf:DisclosureOfDetailedInformationAboutUnrecognizedTemporaryDifferencesAndTaxLossesExplanatory>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember"
      decimals="0"
      id="Fxbrl_20220603113400293"
      unitRef="CAD">6745000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <pmedf:DeductibleTemporaryDifferencesExpiry
      contextRef="C_20200201to20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember"
      id="Fxbrl_202206031134208590">2027 - 2042</pmedf:DeductibleTemporaryDifferencesExpiry>
    <pmedf:DeductibleTemporaryDifferencesExpiry
      contextRef="C_20210201to20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember"
      id="Fxbrl_20220603113420859">2027 - 2042</pmedf:DeductibleTemporaryDifferencesExpiry>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="C_20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfNonCapitalLossesAvailableForFuturePeriodMember"
      decimals="0"
      id="Fxbrl_20220603113450183"
      unitRef="CAD">5116666</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember"
      decimals="0"
      id="Fxbrl_20220603113507959"
      unitRef="CAD">47000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <pmedf:DeductibleTemporaryDifferencesExpiry
      contextRef="C_20200201to20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember"
      id="Fxbrl_202206031135226620">2042 - 2046</pmedf:DeductibleTemporaryDifferencesExpiry>
    <pmedf:DeductibleTemporaryDifferencesExpiry
      contextRef="C_20210201to20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember"
      id="Fxbrl_20220603113522662">2042 - 2046</pmedf:DeductibleTemporaryDifferencesExpiry>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="C_20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfShareIssuanceCostsMember"
      decimals="0"
      id="Fxbrl_20220603113543350"
      unitRef="CAD">69003</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="C_20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember"
      decimals="0"
      id="Fxbrl_20220603113559048"
      unitRef="CAD">84000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
    <pmedf:DeductibleTemporaryDifferencesExpiry
      contextRef="C_20200201to20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember"
      id="Fxbrl_202206031136197600">No expiry</pmedf:DeductibleTemporaryDifferencesExpiry>
    <pmedf:DeductibleTemporaryDifferencesExpiry
      contextRef="C_20210201to20220131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember"
      id="Fxbrl_20220603113619760">No expiry</pmedf:DeductibleTemporaryDifferencesExpiry>
    <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised
      contextRef="C_20210131_ifrsfullTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_pmedfPropertyEquipmentAndIntangibleAssetsMember"
      decimals="0"
      id="Fxbrl_20220603113648389"
      unitRef="CAD">5180</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
</xbrl>
